脳神経科学イラストレイテッド　改訂第3版

出版社： 羊土社
著者：
発行日： 2013-04-01
分野： 臨床医学：内科  >  脳神経科学/神経内科学
ISBN： 9784758120401
電子書籍版： 2013-04-01 （第3版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

7,260 円(税込)

購入する
電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

7,260 円(税込)

購入する

商品紹介

脳神経科学の定番書，2度目の大改訂！ 脳の構造・機能，神経系の発生・再生，高次機能や神経・精神疾患，実験技術など，最新の情報を網羅しました。全イラストをカラー化し，さらにわかりやすくなった完全版です！

目次

  • 脳神経科学イラストレイテッド　改訂第3版

    ―目次―

    第1章 序論　
    　1. 脳神経科学とは
    　2. ニューロン説とシナプス伝達の概念
    　3.脳機能の解明がもたらすもの

    第2章 脳の構造と機能
    　1.脳の概略　
    　2.シナプスの構造と受容体　
    　3.スパインの動態と可塑性　
    　4.大脳新皮質　
    　5.海馬　
    　6.嗅球　
    　7.線条体　
    　8.小脳　

    第3章 神経系の発生と分化
    　1.神経系の成り立ち-神経誘導とパターン形成
    　2.多能性幹細胞からの神経分化
    　3.ニューロンとグリアの分化
    　4.神経細胞の移動と皮質の構築
    　5.成長円錐の走行制御と神経回路形成
    　6.神経発達と臨界期

    第4章 神経系の再生
    　1.成体脳室下帯におけるニューロン新生
    　2.成体脳海馬におけるニューロン新生
    　3.神経再生と細胞治療　
    　4.脊髄損傷後の軸索再生制御機構の解明と軸索再生促進への
    　　　ストラテジー　

    第5章 神経伝達とシナプス可塑性の仕組み
    　1.シナプス伝達　
    　2.シナプス可塑性-長期増強：LTP/長期抑圧：LTD
    　3.電位依存性チャネル
    　4.神経伝達物質と受容体　
    　5.神経栄養因子　

    第6章 脳の高次機能
    　1.視覚　
    　2.聴覚　
    　3.嗅覚
    　4.運動におけるパターン生成の神経機構　
    　5.情動，動機づけ
    　6.記憶と学習　
    　7.遺伝子と行動　
    　8.言語　

    第7章 神経・精神疾患の分子機構
    　1.統合失調症　
    　2.気分障害　
    　3.発達障害-自閉症スペクトラムとADHD　
    　4.ALSなど運動ニューロン病
    　5.アルツハイマー病
    　6.パーキンソン病
    　7.ポリグルタミン病

    第8章 さまざまな実験手法
    　1.電気生理学的手法　
    　2.細胞培養と遺伝子導入　
    　3.in vivo イメージング　
    　4.光操作　
    　5.Functional MRI　
    　6.遺伝子操作マウス　
    　7.網羅的解析

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第1章 序論

P.33 掲載の参考文献
・『絵ときブレインサイエンス入門-脳と神経の科学』 (小林 繁, 他/著), オーム社, 1987
 
・『脳と神経の生物学』(伊藤 薫/著), 培風館, 1996
 
・『Principles of neural science 4th ed.』(Kandel, E. R. etal./ed.), McGraw Hill Companies, Inc., 1999
 
・『The Neuron』(Levitan, I. B. & Kaczmarek, L. K.),Oxford Univ. Press, 1991
 
・Jessell, T. & Kandel, E. R.:Introduction:One decade of Neuron, six decades of neuroscience. Neuron, 20:367-369, 1998
 
・『越境する脳-ブレイン・マシン・インターフェースの最前線』(ミゲル・ニコレリス/著, 鍛原多恵子/訳), 早川書房, 2011
 

第2章 脳の構造と機能

P.44 掲載の参考文献
1) Chemelli, R. M. et al.:Narcolepsy in orexi nknockout mice:molecular genetics of sleepregulation. Cell, 98:437-451, 1999
 
2) Lin, L. et al.:The sleep disorder canine narcolepsyis caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell, 98:365-376, 1999
 
3) Mieda, M. & Yanagisawa, M.:Sleep, feeding, and neuropeptides:roles of orexins and orexin receptors.Curr. Opin. Neurobiol., 12:339-345, 2002
PubMed
4) Tsien, J. Z. et al.:Subregion-and cell type-restricted gene knockout in mouse brain. Cell, 87:1317-1326,1996
PubMed
5) Nakazawa, K. et al.:Requirement for hippocampal CA3 NMDA receptors in associative memory recall.Science, 297:211-218, 2002
PubMed
6) Harris, K. M. & Kater, S. B.:Dendritic spines:cellular specializations imparting both stability and fexibility to synaptic function. Annu. Rev. Neurosci.,17:341-371, 1994
 
7) Schuman, E. M.:mRNA trafficking and local protein synthesis at the synapse. Neuron, 23:645-648, 1999
PubMed
8) Spacek, J.:Three-dimensional analysis of dendriticspines. III. Glial sheath. Anat. Embryol., 171:245-252, 1985
 
9) Ventura, R. & Harris, K. M.:Three-dimensional relationships between hippocampal synapses and astrocytes. J. Neurosci., 19:6897-6906, 1999
 
10) Streit, W. J. & Kreutzberg, G. W.:Response of endogenous glial cells to motor neuron degenerationinduced by toxic ricin. J. Comp. Neurol., 268:248-263, 1988
 
P.51 掲載の参考文献
1) 『Foundations of Neurobiology』(Delcomyn, F.), W. H. Freeman & Co., 1998 (訳書: 『ニューロンの生物学』(小倉明彦, 冨永恵子/訳), 南江堂, 2000)
 
2) 『The fine structure of the nervous system 3rd ed.』(Peters, A. et al.), pp138-211, Oxford University Press, 1991
 
3) Missler, M. et al.:The making of neurexins. J.Neurochem., 71:1339-1347, 1998
PubMed
4) Uemura, T.:The cadherin superfamily at the synapse:more members, more missions. Cell, 93:1095-1098, 1998
PubMed
5) Yuzaki, M.:Cblnl and its family proteins in synapse formation and maintenance. Curr. Opin. Neurobiol.,21:215-220, 2011
 
6) Nusser, Z.:Subcellular distribution of amino acid neurotransmitter receptors and voltage gated channels. 『Dendrites』(Stuart, G. et al./ed.),pp85-113, Oxford University Press, 1999
 
7) Rubio, M. E. & Wenthold, R. J.:Glutamate receptors are selectively targeted to postsynaptic sites in neurons. Neuron, 18:939-950, 1997
PubMed
8) Watanabe, M. et al.:Selective scarcity of NMDA receptor channel subunits in the stratum lucidum (m o s s y f i b r e-r e c i p i e n t l a y e r) o f t h e m o u s e hippocampal CA3 subfield. Eur. J. Neurosci., 10:478-487, 1998
 
9) Nusser, Z. et al.:Cell type and pathway dependence of synaptic AMPA receptor number and variability in the hippocampus. Neuron, 21:545-559, 1998
PubMed
10) Lujan, M. et al.:Perisynaptic location of metabotropic glutamate receptors mGluR1 and mGluR5 on dendrites and dendrititic spines in the rat hippocampus. Eur. J. Neurosci., 8:1488-1500, 1996
 
11) Shigemoto, R. et al.:Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus. J. Neurosci., 17:7503-7522, 1997
PubMed
12) Ohishi, H. et al.:Immunohistochemical localization of metabotropic glutamate receptors, mGluR2 and mGluR3, in rat cerebellar cortex. Neuron, 13:55-66, 1994
PubMed
13) Mitchell, S. J. & Silver, R. A.:Glutamate spillover suppresses inhibition by activating presynaptic mGluRs. Nature, 404:498-502, 2000
PubMed
14) Shigemoto, R. et al.:Target-cell-specific concentration of a metabotropic glutamate receptor in the presynapticctive zone. Nature, 381:523-525, 1996
PubMed
15) Nusser, Z. et al.:Segregation of different GABAA receptors to synaptic and extrasynaptic membranes of cerebellar granule cells. J. Neurosci., 18:1693-1703, 1998
 
16) Kulik, A. et al.:Subcellular localization of metabotropic GABAB receptor subunits GABAB1a/b and GABAB2 in the rat hippocampus. J. Neurosci., 23:11026-11035, 2003
 
17) Kim, E. & Sheng, M.:PDZ domain proteins of synapses. Nat. Rev. Neurosci., 5:771-781, 2003
 
18) O'Brien, R. J. et al.:Activity-dependent modulation of synaptic AMPA receptor accumulation. Neuron, 21:1067-1078, 1998
PubMed
19) Quinlan, E. M. et al.:Rapid, experience-dependent expression of synaptic NMDA receptors in visual cortex in vivo. Nat. Neurosci., 2:352-357, 1999
PubMed
20) Engert, F. & Bonhoeffer, T.:Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature, 399:66-70, 1999
PubMed
21) Matsuzaki, M. et al.:Structural basis of long-term potentiation in single dendritic spines. Nature, 429:761-766, 2004
PubMed
P.57 掲載の参考文献
1) Engert, F. & Bonhoeffer, T.:Dendritic spine changes associated with hippocampal long-term synaptic plasticity. Nature, 399:66-70, 1999
PubMed
2) Maletic-Savatic, M. et al.:Rapid dendritic morphogenesis in CA1 hippocampal dendrites induced by synaptic activity. Science, 283:1923-1927, 1999
PubMed
3) Matsuzaki, M. et al.:Structural basis of long-term potentiation in single dendritic spines. Nature, 429:761-766, 2004
PubMed
4) 河西晴郎ほか: 樹上突起スパインの形態・安定性・機能連関. 蛋白質核酸酵素, 49: 276-281, 2004
 
5) Toni, N. et al.:LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite. Nature, 402:421-425, 1999
 
6) Fukazawa, Y. et al.:Hippocampal LTP is accompanied by enhanced F-actin content within the dendritic spine that is essential for late LTP maintenance in vivo. Neuron, 38:447-460, 2003
PubMed
7) Lamprecht, R. & LeDoux, J.:Structural plasticity and memory. Nat. Rev. Neurosci., 5:45-54, 2004
PubMed
8) Okamoto, K. et al.:Rapid and persistent modulation of actin dynamics regulates postsynaptic reorganization underlying bidirectional plasticity. Nat. Neurosci., 7:1104-1112, 2004
PubMed
9) Segal, M.:Dendritic spines and long-term plasticity.Nat. Rev. Neurosci., 6:277-284, 2005
PubMed
10) Matus, A.:Growth of dendritic spines:a continuing story. Curr. Opin. Neurobiol., 15:67-72, 2005
PubMed
11) 井ノ口馨, 斎藤喜人: スパインアクチンの動態とシナプス形態の可塑性. 蛋白質核酸酵素, 49: 282-286, 2004
 
12) 関野祐子, 他: スパインアクチン骨格は興奮性シナプス成熟を制御する. 蛋白質核酸酵素, 49: 270-275, 2004
 
13) 井ノ口馨: シナプス可塑性におけるスパインアクチン動態の重要性. 『遺伝子制御による「選択的シナプス強化・除去」機構の解明』(狩野方伸/編), pp13-22, クバプロ, 2005
 
14) 笠井陽子, 井ノ口馨: アクチビンによるシナプス形態およびシナプス可塑性の制御. 『遺伝子制御による「選択的シナプス強化・除去」機構の解明』(狩野方伸/編), pp23-38, クバプロ, 2005
 
15) Fischer, M. et al.:Rapid actin-based plasticity in dendritic spines. Neuron, 20:847-854, 1998
PubMed
16) Trachtenberg, J. T. et al.:Long-term in vivo imaging of experience-dependent synaptic plasticity in adult cortex. Nature, 420:788-794, 2002
PubMed
17) Grutzendler, J. et al.:Long-term dendritic spine stability in the adult cortex. Nature, 420:812-816,2002
PubMed
18) Fu, M. et al.:Repetitive motor learning induces coordinated formation of clustered dendritic spines in vivo. Nature, 483:92-95, 2012
PubMed
19) Takahashi, N. et al.:Locally synchronized synaptic inputs. Science, 335:353-356. 2012
PubMed
P.62 掲載の参考文献
1) 『Vergleichende Lokalisationslehre der Grosshirnrinde in ihren Prinzipien dargestellt auf Grund des Zellenbaues』(Brodmann, K.), barth, 1909
 
2) 『Cajal on the cerebral cortex』(DeFelipe, J. & Jones, E. G.), Oxford University Press, 1988
 
3) Tamamaki, N. et al.:Neurons in Golgi-stain-like images revealed by GFP-adenovirus infection in vivo. Neurosci. Res., 38:231-236, 2000
PubMed
4) Wu, S. et al.:Tangential migration and proliferation of intermediate progenitors of GABAergic neurons in the mouse telencephalon. Development, 138:2499-2509, 2011
PubMed
5) 『解剖学カラーアトラス第7版』(Rohen, J. W. et al.), 医学書院, 2012
 
6) Woolsey, C. N.:Organization of somatic sensory and motor areas of the cerebral cortex.『Biological and biochemical bases of behavior』(Harlow, H. F. & Woolsey, C. N. /ed.), The University of Wisconsin Press, pp63-81, 1958
 
P.69 掲載の参考文献
1) 『Memory and Brain』(Squire, L. R.), Oxford University Press, 1987
 
2) Witter, M. P. & Amaral, D. G.:Hippocampal formation.『 The Rat Nervous System, 3rd edition』 (Paxinos, G. /ed.), pp635-704, Academic Press,2004
 
3) Witter, M. P.:Connectivity of the rat hippocampus. 『The Hippocampus New Vistas』(Chan-Palay, V. & Koler, C. /ed.), pp53-69, Alan R. Liss, 1989
 
4) 石塚典生: 海馬の細胞構築と神経結合. 神経研究の進歩, 38: 5-22, 1994
 
5) 石塚典生: 海馬の構造と線維連絡. 脳と神経, 50: 881-892, 1998
 
6) Freund, T. F. & Buzaki, G.:Interneurons of the hippocampus. Hippocampus, 6:347-470, 1996
 
7) Ishizuka, N.:Structural organization of the efferent channels of the subiculum.『Limbic and Association Cortical Systems-Basic, Clinical and Computational Aspects. International Congress Series 1250.』(Ono,T. et al. /ed.), pp121-129, Elsevier, 2003
 
8) Ishizuka, N.:Laminar organization of pyramidal cell layer of the subiculum in the rat. J. Comp. Neurol.,435:89-110, 2001
 
9) Jones, E. G.:Anatomy of cerebral cortex:Columnar input-output organization.『The Organization of the Cerebral Cortex』(Schmitt, F. O. et al. /ed.),pp199-235, The MIT Press, 1981
 
・ Amaral, D. G.:Memory:anatomical organization of candidate brain regions.『Handbook of Physiology』 (Plum, F. /ed.)Sec.1, Vol. V, Part 2, pp211-294, Am.Physiol. Soc., 1987
 
・Amaral, D. G. & Insausti, R.:Hippocampal formation.『The Human Nervous System』(Paxinos, G. /ed.),pp711-755, Academic Press, 1990
 
・『The Temporal Lobe and Limbic System』(Gloor, P.),Oxford University Press, 1997
 
P.78 掲載の参考文献
1) Shepherd, G. M.:Discrimination of molecular signals by the olfactory receptor neuron. Neuron,13:771-790, 1994
PubMed
2) Mori, K. et al.:The olfactory bulb:Coding and processing of odor molecule information. Science,286:711-715, 1999
PubMed
3) Nagao, H. et al.:Grouping and representation of odorant receptors in domains of the olfactory bulb sensory map. Microsc. Res. Tech., 58:168-175,2002
PubMed
4) Mori, K. & Sakano, H.:How is the olfactory map formed and interpreted in the mammalian brain? Annu. Rev. Neurosci., 34:467-499, 2011
 
5) Reed, R. R.:Signaling pathways in odorant detection. Neuron, 8:205-209, 1992
PubMed
6) Menini, A.:Calcium signalling and regulation in olfactory neurons. Curr. Opin. Neurobiol., 9:419-426, 1999
PubMed
7) Buck, L. & Axel, R.:A novel multigene family may encode odorant receptors:a molecular basis for odor recognition. Cell, 65:175-187, 1991
 
8) Mombaerts, P.:Molecular biology of odorant receptors in vertebrates. Annu. Rev. Neurosci., 22:487-509, 1999
PubMed
9) Buck, L. B.:Olfactory receptors and odor coding in mammals. Nutr. Rev., 62:S184-S188, 2004
PubMed
10) Malnic, B. et al.:Combinatorial receptor codes for odors. Cell, 96:713-723, 1999
PubMed
11) Imamura, K. et al.:Coding of odor molecules by mitral/tufted cells in rabbiy olfactory bulb. II.Aromatic compounds. J. Neurophysiol., 68:1986-2002, 1992
 
12) Shepherd, G. M. & Greer, C. A.:Olfactory bulb.『The synaptic organization of the brain, 4th edition』(Shepherd, G. M./ed.), pp159-203, Oxford University Press, 1998
 
13) Uchida, N. et al.:Odor maps in the mammalian olfactory bulb:domain organization and odorant structural features. Nat. Neurosci., 3:1035-1043,2000
PubMed
14) Mori, K. et al.:Maps of odorant molecular features in the mammalian olfactory bulb. Physiol. Rev., 86:409-433, 2006
PubMed
15) Matsumoto, H. et al.:Spatial arrangement of glomerular molecular-feature clusters in the odorant-receptor-class domains of the mouse olfactory bulb. J. Neurophysiol., 103:3490-3500, 2010
PubMed
16) Kobayakawa, K. et al.:Innate versus learned odor processing in the mouse olfactory bulb. Nature,450:503-508, 2007
PubMed
17) Takahashi, Y. K. et al.:Detection and masking of spoiled food smells by odor maps in the olfactory bulb. J. Neurosci., 24:8690-8694, 2004
PubMed
18) Yokoi, M. et al.:Refinement of odor molecule tuning by dendrodendritic synaptic inhibition in the olfactory bulb. Proc. Natl. Acad. Sci. USA, 92:3371-3375, 1995
PubMed
19) Kashiwadani, H. et al.:Synchronized oscillatory discharges of mitral/tufted cells with different molecular receptive ranges in the rabbit olfactory bulb. J. Neurophysiol., 82:1786-1792, 1999
PubMed
20) Igarashi, K. et al.:Parallel mitral and tufted cell pathways route distinct odor information to different targets in the olfactory cortex. J. Neurosci., 32:7970-7985, 2012
PubMed
P.85 掲載の参考文献
1) Alexander, G. E. & Crutcher,:Functional architecture of basal ganglia circuits:neural substrates of parallel processing. Trends Neurosci., 13:266-271, 1990
PubMed
2) 藤山文乃: 大脳基底核の構造(細胞構築と神経回路). Brain Nerve, 61: 341-349, 2009
 
3) 高草木薫: 大脳基底核の機能-パーキンソン病との関連において. 日本生理誌, 65: 113-129, 2003
 
4) 水野昇: 大脳基底核とは. Clin. Neurosci., 16: 14-17, 1998
 
5) 高田昌彦: 大脳基底核をめぐる神経回路. 脳21, 13: 15-22, 2000
 
6) 藤山文乃: 基底核ニューロンの分子マーカー. Clin. Neurosci., 28: 1352-1354, 2010
 
7) 南部 篤: 基底核の機能. Brain Medical, 15: 248-259, 2003
Medical*Online
8) 藤山文乃, 金子武嗣: 大脳基底核の解剖. Clin. Neurosci., 25: 22-24, 2007
 
9) Koshimizu, Y. et al.:A quantitatine analysis of axon bouton distribution of subthalamic nucleus neurons in the rat by single neuron visualization with a uiral vector. J. Comp. Neurol., in press
 
10) Fujiyama, F. et al.:Exclusive and common targets of neostriatofugal projections of rat striosome neurons:a single neuron-tracing study using a viral vector. Eur. J. Neurosci., 33:668-677, 2011
PubMed
11) Fujiyama, F. et al.:Difference in organization of corticostriatal and thalamostriatal synapses between patch and matrix compartments of rat neostriatum.Eur. J. Neurosci., 24:2813-2824, 2006
PubMed
12) Matsuda, W. et al.:Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J. Neurosci., 29:444-453, 2009
PubMed
13) Kimura, M. et al.:Monitoring and switching of cortico-basal ganglia loop functions by the thalamostriatal system. Neurosci. Res., 48:355-360, 2004
PubMed
P.91 掲載の参考文献
1) Miyazaki, M. et al.:P/Q-type Ca2 + channel α 1A regulates synaptic competition on developing cerebellar Purkinje cells. J. Neurosci., 24:1734-1743, 2004
 
2) Jakab, R. L. & Hamori, J.:Quantitative morphology and synaptology of cerebellar glomeruli in the rat.Anat. Embryol., 179:81-88, 1988
PubMed
3) Masugi-Tokita, M. et al.:Number and density of AMPA receptors in individual synapses in the rat cerebellum as revealed by SDS-digested freezefracture replica labeling. J. Neurosci., 27:2135-2144, 2007
PubMed
4) Yamasaki, M. et al.:FGlutamate receptor GluRd2 is essential for input pathway-dependent regulation of synaptic AMPAR contents in cerebellar Purkinje cells. J. Neurosci., 31:3362-3374, 2011.
 
5) Ito, M.:Cerebellar long-term depression:characterization, signal transduction, and functional roles. Physiol. Rev., 81:1143-1195, 2001
PubMed
6) Kashiwabuchi, N. et al.:Impairment of motor coordination Purkinje cell synapse formation and cerebellar long-term depression in GluR δ 2 mutant mice. Cell, 81:245-252, 1995
 
7) Kano, M. et al.:Persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking mGluR1. Neuron, 18:71-79, 1997
PubMed
8) Ichise, T. et al.:mGluR1 in cerebellar Purkinje cells essential for long-term depression synapse elimination and motor coordination. Science, 288:1832-1835, 2000
PubMed
9) Kano, M. et al.:Impaired synapse elimination during cerebellar development in PKC γ mutant mice. Cell, 83:1223-1231, 1995
 
10) Kano, M. et al.:Phospholipase C β 4 is specifically involved in climbing fiber synapse elimination in the developing cerebellum. Proc. Natl. Acad. Sci. USA,95:15724-15729, 1998
 
11) Offermanns, S. et al.:Impaired motor coordination and persistent multiple climbing fiber innervation of cerebellar Purkinje cells in mice lacking G α q. Proc. Natl. Acad. Sci. USA, 94:14089-14094, 1997
 
12) Landsend, A. S. et al.:Differential localization of δ glutamate receptors in the rat cerebellum:coexpression with AMPA receptors in parallel fiberspine synapses and absence from climbing fiberspine synapses. J. Neurosci., 17:834-842, 1997
 
13) Kurihara, H. et al.:Impaired parallel fiber-Purkinje cell synapse stabilization during cerebellar development of mutant mice lacking the glutamate receptor δ 2 subunit. J. Neurosci., 17:9613-9623, 1997
 
14) Matsuda, K. et al.:Cbln1 is a ligand for an orphan glutamate receptor delta2, a bidirectional synapse organizer. Science, 328:363-368, 2010
PubMed
15) Uemura, T. et al.:Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell, 141:1068-1079, 2010
PubMed
16) Ichikawa, R. et al.:Distal extension of climbing fiber territory and multiple innervation caused by aberrant wiring to adjacent spiny branchlets in cerebellar Purkinje cells lacking glutamate receptor GluR δ 2. J. Neurosci., 22:8487-8503, 2002
 
17) Hashimoto, K. et al.:Roles of GluR δ 2 and mGluR1 in climbing fiber synapse elimination during postnatal cerebellar development. J. Neurosci., 21:9701-9712, 2001
 
18) Takeuchi, T. et al.:Control of synaptic connection by glutamate receptor delta2 in the adult cerebellum.J. Neurosci., 25:2146-2156, 2005
PubMed
19) Miyazaki, T. et al.:Ablation of glutamate receptor GluRd2 in adult Purkinje cells causes multiple innervation of climbing fibers by inducing aberrant invasion to parallel fiber innervation territory. J.Neurosci., 30:15196-15209, 2010
 
20) Miyazaki, T. et al.:Cav2.1 in cerebellar Purkinje cells regulates competitive excitatory synaptic wiring, cell survival, and cerebellar biochemical compartmentalization. J. Neurosci., 32:1311-1328,2012
PubMed
21) Iwakura, A. et al.:Lack of molecular-anatomical evidence for GABAergic influence upon axon initial segment of cerebellar Purkinje cells by the pinceau formation J. Neurosci., 32:9438-9448, 2012
PubMed
22) Ichikawa, R. et al.:Developmental switching of perisomatic innervation from climbing fibers to basket cell fibers in cerebellar Purkinje cells. J.Neurosci., 31:16916-16927, 2011
PubMed
23) Nakayama, H. et al.:GABAergic inhibition regulates developmental synapse eliminatiom in the cerebellum. Neuron, 74:384-396, 2012
PubMed
24) Mugnaini, E. et al.:The unipolar brush cells of the mammalian cerebellum and cochlear nucleus:cytology and microcircuitry. Prog. Brain Res., 114:131-150, 1997
PubMed
25) Ohno-Shosaku, T. et al.:Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals.Neuron, 29:729-738, 2001
PubMed
26) Maejima, T. et al.:Synaptically driven endocannabinoid release requires Ca2+ -assisted metabotropic glutamate receptor subtype 1 to phospholipase C β 4 signaling cascade in the cerebellum. J. Neurosci., 25:6826-6835, 2005
 
・『Neuroanatomy Text and Atlas, 3rd edition』(Martin, J..), McGraw-Hill, 2003
 

第3章 神経系の発生と分化

P.104 掲載の参考文献
1) Langeland, J. A. & Kimmel, C. B.:Fishes.『 Embryology:Constructing the organism』(Gilbert, S. F./ ed.),pp383-407, Sinauer Associates, 1997
 
2) Higashijima, S. et al.:Visualization of cranial motor neurons in live transgenic zebrafish expressing green fluorescent protein under the control of the Islet-1 promoter/enhancer. J. Neurosci., 20:206-218, 2000
PubMed
3) Gilbert, S. F.:『Developmental Biology(5th edition)』,Sinauer Associates, 1997
 
4) 『The heritage of experimental embryo-logy:HansSpemann and the organizer』 (Hamburger, V.).Oxford University. Press, 1988
 
5) Kodjabachian, L. et al.:Gastrulation in zebrafish:What mutants teach us. Devel. Bid., 213:231-245,1999
 
6) Ruiz, I. & Altaba, A.:Planar and vertical signals in the induction and patterning of the Xenopus nervous system. Development, 115:67-80, 1992
 
7) Moore, K. L. & Persaud, T. V. N.:Essentials of Embryology and Birth Defects. W. B. Sounders,Philadelphia, 1993
 
8) 岡本 仁: 神経組織の領域化と特異化. 『分子神経生物学入門』(金子章道, 他/編), pp17-32, 共立出版, 1999
 
9) 岡本 仁: ゼブラフィッシュのHox遺伝子から見た脊椎動物の進化と多様化. 生体の科学, 49: 546-554, 1999
 
10) Arendt, D. & Nubler-Jung, K.:Comparison of early nerve cord development in insects and vertebrates.Development, 126:2309-2325, 1999
PubMed
11) Shimamura, K. et al.:Longitudinal organization of the anterior neural plate and neural tube.Development, 121:3923-3933, 1995
PubMed
12) Tanabe, Y. & Jessell, T. M.:Divorsity and pattern in the developing spinal cord. Science, 274:1115-1123, 1996
PubMed
13) Jessell, T. M. & Lumsden, A.:Inductive signals and the assignment of cell fate in the spinal cord and hindbrain.『 Molecular and Cellular Approaches to neural Development』(Cowan, W. M. et al./ed.),pp290-333, Oxford University. Press, 1997
 
14) Hynes, M. & Rosenthal, A.:Specification of dopaminergic and serotonergic neurons in the vertebrate CNS. Curr. Opin. Neurobiol., 9:26-36,1999
PubMed
15) Guo, S. et al.:Development of noradrenergic neurons in the zebrafish hindbrain requires BMP, FGF8, and the homeodomain protein Soulless/Phox2a. Neuron,24:555-566, 1999
PubMed
16) 岡本 仁: ゼブラフィッシュの脊髄と運動神経細胞の分化-転写因子と組織間相互作用の役割. 生体の科学, 45: 182-188, 1994
 
17) 岡本 仁: Islet-1 ファミリーと神経系の分化. 『神経回路形成と機能発達』(津本忠治, 他/編), 共立出版, 2000
 
18) 平良眞規: LIMホメオドメインタンパク質. 実験医学(増刊), 17: 320-329, 1999
 
P.111 掲載の参考文献
1) Reynolds, B. A. & Weiss, S.:Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science, 255:1707-1710, 1992
PubMed
2) Kilpatrick, T. J. & Bartlett, P. F.:Cloning and growth of multipotential neural precursors:requirementsfor proliferation and differentiation. Neuron, 10:255-265, 1993
 
3) Davis, A. A. & Temple, S.:A self-renewing multipotential stem cell in embryonic rat cerebral cortex. Nature, 372:263-266, 1994
 
4) Palmer, T. D. et al.:FGF-2-responsive neuronal progenitors reside in proliferative and quiescent regions of the adult rodent brain. Mol. Cell.Neurosci., 6:474-486, 1995
PubMed
5) Bain, G. et al.:Embryonic stem cells express neuronal properties in vitro. Dev. Biol., 168:342-357, 1995
PubMed
6) Renoncourt, Y. et al.:Neurons derived in vitro from ES cells express homeoproteins characteristic of motoneurons and interneurons. Mech. Dev., 79:185-197, 1998
PubMed
7) Lee, S. H. et al.:Efficient generation of midbrain and hindbrain neurons from mouse embryonic stemcells. Nat. Biotechnol., 18:675-679, 2000
 
8) Wichterle, H. et al.:Directed differentiation of embryonic stem cells into motor neurons. Cell,110:385-397, 2002
PubMed
9) Okada, Y. et al.:Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stemcells. Dev. Biol., 275:124-142, 2004
 
10) Shimozaki, K. et al.:Stage-and site-specific DNA demethylation during neural cell development from embryonic stem cells. J. Neurochem., 93:432-439,2005
PubMed
11) Watanabe, K. et al.:Directed differentiation of telencephalic precursors from embryonic stem cells.Nat. Neurosci., 8:288-296, 2005
PubMed
12) Su, H. L. et al.:Generation of cerebellar neuron precursors from embryonic stem cells. Dev. Biol.,290:287-296, 2006
PubMed
13) Gaspard, N. & Vanderhaeghen, P.:Mechanisms of neural specification from embryonic stem cells. Curr. Opin. Neurobiol., 20:37-43, 2010
PubMed
14) Gaspard, N. et al.:An intrinsic mechanism of corticogenesis from embryonic stem cells. Nature,455:351-357, 2008
PubMed
15) Eiraku, M. et al.:Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell, 3:519-532, 2008
PubMed
16) Takahashi, K. & Yamanaka, S.:Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell,126:663-676, 2006
PubMed
17) Takahashi, K. et al.:Induction of pluripotent stemcells from adult human fibroblasts by defined factors.Cell, 131:861-872, 2007
 
18) Okita, K. et al.:Generation of mouse induced pluripotent stem cells without viral vectors. Science,322:949-953, 2008
PubMed
19) Soldner, F. et al.:Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell, 136:964-977, 2009
PubMed
20) Woltjen, K. et al.:piggy Back transposition reprograms fibroblasts to induced pluripotent stem cells. Nature,458:766-770, 2009
 
21) Yu, J. et al.:Human induced pluripotent stem cells free of vector and transgene sequences. Science, 324:797-801, 2009
PubMed
22) Miura, K. et al.:Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol., 27:743-745, 2009
PubMed
23) Fujimoto, Y. et al.:Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing Neuroepithelial-like stem cells. Stem Cells, 30:1163-1173, 2012
PubMed
24) Vierbuchen, T. et al.:Direct conversion of fibroblasts to functional neurons by defined factors. Nature,463:1035-1041, 2010
PubMed
25) Pang, Z. P. et al.:Induction of human neuronal cells by defined transcription factors. Nature, 476:220-223, 2011
PubMed
26) Matsui, T. et al.:Neural stem cells directly differentiated from partially reprogrammed fibroblasts rapidlycquire gliogenic competency. Stem Cells, 30:1109-1119, 2012
PubMed
27) Szabo, E. et al.:Direct conversion of human fibroblasts to multilineage blood progenitors. Nature, 468:521-526, 2010
PubMed
28) Efe, J. A. et al.:Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nat. Cell Biol., 13:215-222, 2011
PubMed
29) Hiramatsu, K. et al.:Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors. J. Clin. Invest., 121:640-657, 2011
PubMed
P.119 掲載の参考文献
1) Temple, S.:The development of neural stem cells.Nature, 414:112-117, 2001
PubMed
2) Fode, C. et al.:A role for neural determination genes in specifying the dorsoventral identity of telencephalic neurons. Genes Dev., 14:67-80, 2000
PubMed
3) Ohsawa, R. et al.:Mash1 and Math3 are required for development of branchiomotor neurons and maintenance of neural progenitors. J. Neurosci.,25:5857-5865, 2005
PubMed
4) Rowitch, D. H. & Kriegstein, A. R.:Developmental genetics of vertebrate glial-cell specification. Nature,468:214-222, 2010
PubMed
5) Fukuda, S. & Taga, T.:Cell fate determination regulated by a transcriptional signal network in the developing mouse brain. Anat. Sci. Int., 80:12-18,2005
PubMed
6) Nakashima, K. et al.:Synergistic signaling in fetal brain by STAT3-Smad1 complex bridged by p300.Science, 284:479-482, 1999
PubMed
7) Namihira, M. et al.:Committed neuronal precursors confer astrocytic potential on residual neural precursor cells. Dev. Cell, 16:245-255, 2009
PubMed
8) Li, H. et al.:Phosphorylation regulates OLIG2 cofactor choice and the motor neuron-oligodendrocyte fate switch. Neuron, 69:918-929, 201
 
9) Hirabayashi, Y. & Gotoh, Y.:Epigenetic control of neural precursor cell fate during development. Nat.Rev. Neurosci., 11:377-388, 2010
PubMed
10) Hu, X. L. et al.:Epigenetic control on cell fate choice in neural stem cells. Protein Cell, 3:278-290, 2012
PubMed
11) 鹿川哲史, 他: アストロサイトの発生・分化. Clinical Neuroscience, 29: 1239-1242, 2011
 
P.128 掲載の参考文献
1) 仲嶋一範: 発生期大脳皮質における移動神経細胞のダイナミクス. 『ブレインサイエンス・レビュー2009』(ブレインサイエンス振興財団/編), pp207-232, クバプロ, 2009
 
2) Sekine, K. et al.:Cell polarity and initiation of migration. Dev. Neurosci., A Comprehensive Reference, in press
 
3) 森本桂子, 仲嶋一範: 発生期大脳皮質におけるニューロンの移動と配置のダイナミクス. 実験医学, 25: 338-345, 2007
Medical*Online
4) 仲嶋一範: 大脳皮質の層形成「制御」因子リーリンは, 何を「制御」しているのか?. 生化学, 83: 727-731, 2011
 
5) Molnar, Z. et al.:Comparative aspects of cerebral cortical development. Eur. J. Neurosci., 23:921-934, 2006
PubMed
・仲嶋一範: ニューロンの移動と層および神経核の形成, 『脳の発生学(仮題)』(宮田卓樹, 山本亘彦/編), 化学同人, 印刷中
 
・Honda, T. et al.:Regulation of cortical neuron migration by the Reelin signaling pathway. Neurochem. Res.,36:1270-1279, 2011
PubMed
・Nakajima, K.:Control of tangential/non-radial migration of neurons in the developing cerebral cortex.Neurochem. Int., 51:121-131, 2007
PubMed
・Jossin, Y.:Neuronal migration and the role of reelin during early development of the cerebral cortex. Mol.Neurobiol., 30:225-251, 2004
PubMed
・Wang, X. et al.:A new subtype of progenitor cell inthe mouse embryonic neocortex. Nat. Neurosci., 14:555-561, 2011
 
・Rubenstein, J. L.:Annual Research Review:Development of the cerebral cortex:implications for neurodevelopmental disorders. J. Child Psychol. Psychiatry., 52:339-355,2011
PubMed
P.136 掲載の参考文献
1) Raper, J. A. & Tessier-Lavigne, M.:Growth cones and axon pathfinding.『Fundamental Neuroscience,Chapter 18』(Squire, L. et al./ed.), pp519-546,Academic Press, 1999
 
2) Tessier-Lavigne, M. & Goodman, C. S.:The molecular biology of axon guidance. Science, 274:1123-1133, 1996
PubMed
3) Lowery, L. A. & Van Vactor, D.:The trip of the tip:understanding the growth cone machinery. Nat. Rev.Mol. Cell. Biol., 10:332-343, 2009
PubMed
4) Tojima, T. et al.:Second messengers and membrane trafficking direct and organize growth cone steering.Nat. Rev. Neurosci., 12:191-203, 2011
PubMed
5) Lichtman, J. W. et al.:Synapse formation and elimination.『 Fundamental neuroscience, chapter 19』(Squire, L. et al./ed.), pp547-580, Academic Press,1999
 
6) Ziv, N. E. & Smith, S. J.:Evidence for a role of dendritic filopodia in synaptogenesis and spine formation. Neuron, 17:91-102, 1996
PubMed
7) Yoshihara, Y. et al.:Dendritic spine formation and stabilization. Curr. Opin. Neurobiol., 19:146-153, 2009
 
8) Siddiqui, T. J. & Craig, A. M.:Synaptic organizing complexes. Curr. Opin. Neurobiol., 21:132-143, 2001
 
9) Sudhof, T. C.:Neuroligins and neurexins link synaptic function to cognitive disease. Nature, 455:903-911, 2008
PubMed
10) Katz, L. C. & Shatz, C. J.:Synaptic activity and the construction of cortical circuits. Science, 274:1133-1138, 1996
PubMed
P.141 掲載の参考文献
1) McLaughlin, T. & O'Leary, D. D.:Molecular gradients and development of retinotopic maps.Annu. Rev. Neurosci., 28:327-355, 2005
PubMed
2) Dalva, M. B. et al.:EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell, 103:945-956, 2000
PubMed
3) Blankenship, A. G. & Feller, M. B.:Mechanisms underlying spontaneous patterned activity in developing neural circuits. Nat. Rev. Neurosci., 11:18-29, 2010
PubMed
4) van Zundert, B. et al.:Receptor compartmentalization and trafficking at glutamate synapses:a developmental proposal. Trends Neurosci., 27:428-437, 2004
PubMed
5) Shepherd, J. D. & Huganir, R. L.:The cell biology of synaptic plasticity:AMPA receptor trafficking. Annu.Rev. Cell Dev. Biol., 23:613-643, 2007
PubMed
6) Yoshii, A. et al.:Eye opening induces a rapid dendritic localization of PSD-95 in central visual neurons. Proc. Natl. Acad. Sci. USA, 100:1334-1339, 2003
PubMed
7) Yoshii, A. et al.:TrkB and protein kinase M ζ regulate synaptic localization of PSD-95 in developing cortex. J. Neurosci., 31:11894-11904,2011
 
8) Yoshii, A. & Constantine-Paton, M.:BDNF induces transport of PSD-95 to dendrites through PI3K-AKT signaling after NMDA receptor activation. Nat.Neurosci., 10:702-711, 2007
PubMed
9) Hubel, D. H. et al.:Plasticity of ocular dominance columns in monkey striate cortex. Philos. Trans. R.Soc. Lond. B. Biol. Sci., 278:377-409, 1977
PubMed
10) Holtmaat, A. & Svoboda, K.:Experience-dependent structural synaptic plasticity in the mammalian brain. Nat. Rev. Neurosci., 10:647-658, 2009
PubMed
11) Huang, Z. J. et al.:BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell, 98:739-755, 1999
PubMed
12) Pizzorusso, T. et al.:Reactivation of ocular dominance plasticity in the adult visual cortex. Science, 298:1248-1251, 2002
PubMed
13) Syken, J. et al.:PirB restricts ocular-dominance plasticity in visual cortex. Science, 313:1795-1800,2006
PubMed
14) McGee, A. W. et al.:Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor.Science, 309:2222-2226, 2005
PubMed
15) Morishita, H. et al.:Lynx1, a cholinergic brake,limits plasticity in adult visual cortex. Science, 330:1238-1240, 2010
PubMed

第4章 神経系の再生

P.148 掲載の参考文献
1) Alvarez-Buylla, A. & Garcia-Verdugo, J. M.:Neurogenesis in adult subventricular zone. J. Neurosci.,22:629-634, 2002
PubMed
2) Reynolds, B. A. et al.:A multipotent EGFresponsive striatal embryonic progenitor cell produces neurons and astrocytes. J. Neurosci., 12:4565-4574, 1992
PubMed
3) 岡野栄之: adult brainにおける神経幹細胞の存在とneurogenesis. 細胞工学, 18: 687-689, 1999
 
4) Temple, S. & Alvarez-Buylla, A.:Stem cells in the adult mammalian central nervous system. Curr.Opin. Neurobiol., 9:135-141, 199
 
5) 澤本和延, 岸本憲人: 脳室壁付近に存在する成体神経幹細胞ニッチの機能と進化. 細胞工学, 27: 681-685, 2008
 
6) 澤本和延: 幹細胞ニッチ. 『遺伝子医学MOOK別冊 ますます重要になる細胞周辺環境の科学技術』(田畑泰彦/編), メディカルドゥ, pp267-273, 2009
 
7) Ihrie, R. A. & Alvarez-Buylla, A.:Lake-front property:a unique germinal niche by the lateral ventricles of the adult brain. Neuron, 70:674-686,2011
PubMed
8) Ming, G. L. & Song, H.:Adult neurogenesis in the mammalian brain:significant answers and significant questions. Neuron, 70:687-702, 2011
PubMed
9) 金子奈穂子, 澤本和延: 成体脳におけるニューロン新生と脳梗塞後の神経新生メカニズム. 実験医学, 26: 224-229, 2008
 
10) Kokaia, Z. & Lindvall, O.:Neurogenesis after ischaemic brain insults. Curr. Opin. Neurobiol., 13:127-132, 2003
PubMed
・『Neurogenesis in the adult brain I』(Seki, T. et al. /ed.), Springer, 2011
 
・『Neurogenesis in the adult brain II』(Seki, T. et al. /ed.), Springer, 2011
 
・『Adult neurogenesis 2』(Kempermann, G.), Oxford University Press, 2010
 
・『再生医療叢書 第七巻 神経系』(岡野栄之, 出澤真理/編), 朝倉書店, 2013
 
P.153 掲載の参考文献
1) Eriksson, P. S. et al.:Neurogenesis in the adult hippocampus. Nat. Med., 4:1313-1317, 1998
PubMed
2) Kempermann, G. & Gage, F. H. : 大人でも脳細胞は新生する. 日経サイエンス, 8: 36-42, 1999
 
3) Abrous, D. N. et al.:Adult neurogenesis:from precursors to network and physiology. Physiol. Rev.,85:523-569, 2005
PubMed
4) Schmidt-Hieber, C. et al.:Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus. Nature, 429:184-187, 2004
PubMed
5) Marin-Burgin, A. et al.:Unique processing during a period of high excitation/inhibition balance in adultborn neurons. Science, 335:1238-1242, 2012
PubMed
6) McHugh, T. J. et al.:Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network. Science, 317:94-99, 2007
PubMed
7) Clelland, C. D. et al.:A functional role for adult hippocampal neurogenesis in spatial pattern separation. Science, 325:210-213, 2009
PubMed
8) Sahay, A. et al.:Increasing adult hippocampal neurogenesis is sufficient to improve pattern separation. Nature, 472:466-470, 2011
PubMed
9) Nakashiba, T. et al.:Young dentate granule cells mediate pattern separation, whereas old granule cells facilitate pattern completion. Cell, 149:188-201, 2012
PubMed
10) Kitamura, T. et al.:Adult neurogenesis modulatesthe hippocampus-dependent period of associative fear memory. Cell, 139:814-827, 2009
PubMed
11) Santarelli, L. et al.:Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301:805-809, 2003
PubMed
12) Snyder, J. S. et al.:Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature, 476:458-461, 2011
PubMed
13) Fukuda, S. et al.:Two distinct subpopulations of nestin-positive cells in adult mouse dentate gyrus. J. Neurosci., 23:9357-9366, 2003
PubMed
14) Kempermann, G. et al.:Milestones of neuronal development in the adult hippocampus. Trends Neurosci., 27:447-452, 2004
PubMed
15) Aizawa, K. et al.:Primate-specific alterations in neural stem/progenitor cells in the aged hippocampus. Neurobiol. Aging, 32:140-150, 2011
PubMed
16) Villeda, S. A. et al.:The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature, 477:90-94, 2011
PubMed
17) Tozuka, Y. et al.:GABAergic excitation promotes neuronal differentiation in adult hippocampal progenitor cells. Neuron, 47:803-815, 2005
PubMed
18) Mu, Y. & Gage, F. H.:Adult hippocampal neurogenesis and its role in Alzheimer's disease. Mol. Neurodegener.,6:85, 2011
PubMed
19) Li, G. et al.:GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult Apolipoprotein E4 knockin mice. Cell Stem Cell, 5:634-645, 2009
PubMed
20) Sun, B. et al.:Imbalance between GABAergic and glutamatergic transmisson imparis adult neurogenesis in an animal model of Alzheimer'sdisease. Cell Stem Cell, 5:624-633, 2009
 
P.160 掲載の参考文献
1) Freed, C. R. et al.:Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N.Engl. J. Med., 344:710-719, 2001
PubMed
2) Olanow, C. W. et al.:A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson'sdisease. Ann. Neurol., 54:403-414, 2003
 
3) Kawasaki, H. et al.:Induction of midbrain dopaminergicneurons from ES cells by stromal cell-derived inducing activity. Neuron, 28:31-40, 2000
 
4) Lee, S. H. et al.:Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat. Biotechnol., 18:675-679, 2000
PubMed
5) Kriks, S. et al.:Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature, 480:547-551, 2011
PubMed
6) Hedlund, E. et al.:Embryonic stem cell-derived Pitx3-enhanced green fluorescent protein midbrain dopamine neurons survive enrichment by fluorescence-activated cell sorting and function in an animal model of Parkinson's disease. Stem Cells, 26:1526-1536, 2008
 
7) Ono, Y. et al.:Differences in neurogenic potential in floor plate cells along an anteroposterior location:midbrain dopaminergic neurons originate from mesencephalic floor plate cells. Development, 134:3213-3225, 2007
PubMed
8) Chung, S. et al.:ES cell-derived renewable and functional midbrain dopaminergic progenitors. Proc.Natl. Acad. Sci. USA, 108:9703-9708, 2011
PubMed
9) Mendez, I. et al.:Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain, 128:1498-1510, 2005
PubMed
10) Wernig, M. et al.:Functional integration of embryonicstem cell-derived neurons in vivo. J. Neurosci., 24:5258-5268, 2004
 
11) Cho, M. S. et al.:Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci.USA, 105:3392-3397, 2008
PubMed
12) Takagi, Y. et al.:Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J. Clin. Invest., 115:102-109, 2005
 
13) Doi, D. et al.:Prolonged maturation culture favors a reduction in the tumorigenicity and the dopaminergic function of human ESC-derived neural cells in a primate model of Parkinson's disease. Stem Cells, 30:935-945, 2012
 
14) Kikuchi, T. et al.:Survival of human induced pluripotent stem cell-derived midbrain dopaminergic neurons in the brain of a primate model Parkinson's disease. J. Parkinson's Disease., 1:395-412, 2011
PubMed
15) Brederlau, A. et al.:Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease:effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells,24:1433-1440, 2006
PubMed
16) Fukuda, H. et al.:Fluorescence-activated cell sorting-based purification of embryonic stem cellderived neural precursors averts tumor formation after transplantation. Stem Cells, 24:763-771, 2006
PubMed
17) Pruszak, J. et al.:CD15, CD24 and CD29 define a surface biomarker code for neural lineage differentiation of stem cells. Stem Cells, 27:2928-2940, 2009
PubMed
18) Okita, K. et al.:A more efficient method to generate integration-free human iPS cells. Nat. Methods, 8:409-412, 2011
PubMed
19) Schwartz, S. D. et al.:Embryonic stem cell trial for macular degeneration:a preliminary report. Lancet,379:713-720, 2012
PubMed
20) Wenning, G. K. et al.:Short-and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease. Ann. Neurol., 42:95-107, 1997
 
21) Hagell, P. et al.:Sequential bilateral transplantation in Parkinson's disease:effects of the second graft.Brain, 122:1121-1132, 1999
PubMed
22) Hauser, R. A. et al.:Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch. Neurol., 56:179-187, 1999
PubMed
23) Piccini, P. et al.:Dopamine release from nigral transplants visualized in vivo in a Parkinson's patient. Nat. Neurosci., 2:1137-1140, 1999
 
24) Brundin, P. et al.:Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in. Parkinson's disease. Brain, 123:1380-1390, 2000
PubMed
25) Freed, C. R. et al.:Placebo surgery in trials of therapy for Parkinson's disease. N. Engl. J. Med.,342:353-355, 2000
PubMed
26) Olanow, C. W. et al.:A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease. Ann. Neurol., 54:403-414, 2003
PubMed
27) Mendez, I. et al.:Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease. Brain, 128:1498-1510, 2005
PubMed
28) Isacson, O. et al.:Parkinson's disease:interpretationsof transplantation study are erroneous. Nat.Neurosci., 4:553, 2001
PubMed
29) 脳プロブレム!. jp『パーキンソン病DBS』 (http://www.nouproblem.jp/DBS/index.html)
 
P.166 掲載の参考文献
1) Neumann, S. & Woolf, C. J.:Regeneration of dorsal column fibers into and beyond the lesion site following adult spinal cord injury. Neuron, 23:83-91, 1999
PubMed
2) Chen, M. S. et al.:Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature, 403:434-439,2000
 
3) GrandPre, T. et al.:Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature, 403:439-444, 2000
PubMed
4) Liu, B. P. et al.:Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science,297:1190-1193, 2002
PubMed
5) Domeniconi, M. et al.:Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth. Neuron, 35:283-290, 2002
PubMed
6) Wang, K. C. et al.:Oligodendrocyte-myelin glycoproteinis a Nogo receptor ligand that inhibits neuriteutgrowth. Nature, 417:941-944, 2002
 
7) Jones, L. L. et al.:NG2 is a major chondroitin sulfate proteoglycan produced after spinal cord injury and is expressed by macrophages and oligodendrocyte progenitors. J. Neurosci., 22:2792-2803, 2002
 
8) Pasterkamp, R. J. et al.:Peripheral nerve injury fails to induce growth of lesioned ascending column axons into spinal cord scar tissue expressing the axon repellent Semaphorin3A. Eur. J. Neurosci.,13:457-471, 2001
PubMed
9) De Winter, F. et al.:Injury-induced class 3 semaphorin expression in the rat spinalcord. Exp. Neurol., 175:61-75, 200
 
10) Fournier, A. E. et al.:Identification of a receptor mediating Nogo-66 inhibition of anoxal regeneration. Nature, 409:341-346, 2001
 
11) Wang, K. C. et al.:p75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp.Nature, 420:74-78, 2002
PubMed
12) Yamashita, T. et al.:The p75 receptor transducesthe signal from myelin-associated glycoprotein to Rho. J. Cell Biol., 157:565-570, 2002
 
13) Yamashita, T. et al.:Neurotrophin binding to the p75 receptor modulates Rho activity and axonal outgrowth. Neuron, 24:585-593, 1999
 
14) Mi, S. et al.:LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat.Neurosci., 7:221-228, 2004
PubMed
15) Park, J. B. et al.:A TNF receptor family member,TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors.Neuron, 45:345-351, 2005
PubMed
16) Shao, Z. et al.:TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron, 45:353-359, 2005
PubMed
17) Zheng, B. et al.:Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron, 38:213-224, 2003
PubMed
18) Simonen, M. et al.:Systemic deletion of the myelinassociated outgrowth inhibitor Nogo-A improvesegenerative and plastic responses after spinal cord injury. Neuron, 38:201-211, 2003
PubMed
19) Kim, J. E. et al.:Axon regeneration in young adultmice lacking Nogo-A/B. Neuron, 38:187-199, 2003
 
20) Zheng, B. et al.:Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.Proc. Natl. Acad. Sci. USA, 102:1205-1210, 2005
 
21) Kim, J. E. et al.:Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.Neuron, 44:439-451, 2004
PubMed
22) Bradbury, E. J. et al.:Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature, 416:636-640, 2002
PubMed
23) Kaneko, S. et al.:A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat. Med., 12:1380-1389, 2006
PubMed
24) Qiu, J. et al.:Spinal axon regeneration induced by elevation of cyclic AMP. Neuron, 34:895-903, 2002
PubMed
25) Qiu, J. et al.:Conditioning injury-induced spinal axon regeneration requires signal transducer andactivator of transcription 3 activation. J. Neurosci.,25:1645-1653, 2005
 
26) Park, K. K. et al.:Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science, 322:963-966, 2008
PubMed
27) Liu, K. et al.:PTEN deletion enhances the regenerative ability of adult corticospinal neurons. Nat. Neurosci., 13:1075-1081, 2010
PubMed

第5章 神経伝達とシナプス可塑性の仕組み

P.175 掲載の参考文献
1) Schneggenburger, R. & Neher, E.:Presynaptic calcium and control of vesicle fusion. Curr. Opin.Neurobiol., 15:266-274, 2005
PubMed
2) Schenck, S. et al.:A chloride conductance in VGLUT1 underlies maximal glutamate loading into synaptic vesicles. Nat. Neurosci., 12:156-162, 2009
PubMed
3) Hida, Y. & Ohtsuka, T.:CAST and ELKS proteins:structural and functional determinants of the presynaptic active zone. J. Biochem., 148:131-137,2010
 
4) Haucke, V. et al.:Protein in the coupling of synaptic exocytosis and endocytosis. Nat. Rev. Neurosci.,12:127-138, 2011
PubMed
5) Chen, Y. A. & Scheller, R. H.:SNARE-mediated membrane fusion. Nat. Rev. Mol. Cell Biol., 2:98-106, 2001
PubMed
6) Yokoyama, C. T. et al.:Mechanism of SNARE protein binding and regulation of Cav2 channels by phosphorylation of the synaptic protein interactionsite. Mol. Cell. Neurosci., 28:1-17, 2005
 
7) Kaeser, P. S. et al.:RIM proteins tether Ca2 +channels to presynaptic active zones via a direct PDZ-domain interaction. Cell, 144:282-295, 2011
 
8) Yamaguchi, K. et al.:A GDP/GTP exchange protein for the Rab3 small G protein family up-regulates apostdocking step of synaptic exocytosis in centralsynapses. Proc. Natl. Acad. Sci. USA, 99:14536-14541, 2002
PubMed
9) Young, S. M. Jr. & Neher, E.:Synaptotagmin has an essential function in synaptic vesicle positioning for synchronous release in addition to its role as a calcium sensor. Neuron, 63:482-496, 2009
PubMed
10) Miller, A. N. & Long, S. B.:Crystal structure of thehuman two-pore domain potassium channel K2P1.Science, 335:432-436, 2012
 
P.176 掲載の参考文献
・『新生理学 第4版』(小幡邦彦, 他/著), 文光堂, 2003
 
・山口和彦: 神経興奮とシナプス伝達の分子メカニズム. 『分子・細胞・シナプスからみる脳』(古市禎一/編), pp55-90, 東京大学出版会, 2008
 
P.183 掲載の参考文献
1) Nicoll, R. A. & Malenka, R. C.:Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature, 377:115-118, 1995
PubMed
2) 渡部文子, 真鍋俊也: 神経(2)神経可塑性. 『イラストで徹底理解する シグナル伝達キーワード事典』(山本 雅, 仙波憲太郎, 山梨裕司/編), pp266-273, 羊土社, 2012
 
3) Manabe, T. et al.:Postsynaptic contribution to longterm potentiation revealed by the analysis of miniature synaptic currents. Nature, 355:50-55, 1992
PubMed
4) Yamagata, Y. et al.:Kinase-dead knock-in mouse reveals an essential role of kinase activity of Ca2+/calmodulin-dependent protein kinase II alpha in dendritic spine enlargement, long-term potentiation, and learning. J. Neurosci., 29:7607-7618, 2009
 
5) Lisman, J. et al.:The molecular basis of CaMK function in synaptic and behavioural memory. Nat.Rev. Neurosci., 3:175-190, 2002
PubMed
6) Hayashi, Y. et al.:Driving AMPA receptors into synapses by LTP and CaMK II:requirement for GluR1 and PDZ domain interaction. Science, 287:2262-2267, 2000
PubMed
7) Barria, A. et al.:Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-K II during long-term potentiation. Science, 276:2042-2045,1997
 
8) Harris, E. W. & Cotman, C. W.:Long-term potentiation of guinea pig mossy fiber responses is not blocked by N-methyl D-aspartate antagonists. Neurosci. Lett.,70:132-137, 1986
PubMed
9) Nicoll, R. A. & Schmitz, D.:Synaptic plasticity at hippocampal mossy fibre synapses. Nat. Rev.Neurosci., 6:863-876, 2005
PubMed
10) Castillo, P. E. et al.:RIM1 alpha is required for presynaptic long-term potentiation. Nature, 415:327-330, 2002
 
11) Ito, M.:The molecular organization of cerebellar long-term depression. Nat. Rev. Neurosci., 3:896-902, 2002
PubMed
12) Aiba, A. et al.:Deficient cerebellar long-term depression and impaired motor learning in mGluR1 mutant mice. Cell, 79:377-388, 1994
PubMed
13) Lisman, J.:A mechanism for the Hebb and the anti-Hebb processes underlying learning and memory.Proc. Natl. Acad. Sci. USA, 86:9574-9578, 1989
 
14) Carroll, R. C. et al.:Role of AMPA receptor endocytosis in synaptic plasticity. Nat. Rev. Neurosci., 2:315-324, 2001
PubMed
15) Nicoll, R. A. et al.:The current excitement in longterm potentiation. Neuron, 1:97-103, 1988
PubMed
P.192 掲載の参考文献
1) 『イオンチャネル最前線update』(倉智嘉久/編), 別冊医学のあゆみ, 医歯薬出版, 2005
 
2) Payandeh, J. et al.:The crystal structure of a voltage-gated sodium channel. Nature, 475:353-358, 2011
PubMed
3) Catterall, W. A. et al.:International Union of Pharmacology. XL VIII. Nomenclature and structurefunction relationships of voltage-gated calcium channels. Pharmacol. Rev., 57:411-425, 2005
 
4) Bender, K. J. & Trussell, L. O.:The physiology of the axon initial segment. Annu. Rev. Neurosci., 35:249-265, 2012
PubMed
5) Kiyonaka, S. et al.:RIM1 confers sustained activity and neurotransmitter vesicle anchorong to presynaptic Ca2+ channels. Nat. Neurosci., 10:691-701, 2007
PubMed
6) Uriu, Y. et al.:Rab3-interacting molecule γ isoforms lacking the Rab3-binding domain induce long lasting currents but block neurotransmitter vesicle anchoring in voltage-dependent P/Q-type Ca2+ channels. J. Biol. Chem., 285:21750-21767,2010
 
7) Coppola, T. et al.：Direct interaction of the Rab3 effector RIM with Ca2+ channels, SNAP-25, and synaptotagmin. J. Biol. Chem., 276：32756-32762, 2001
PubMed
8) Kaeser, P. S. et al.:RIM proteins tether Ca2+ channels to presynaptic active zones via a direct PDZ-domain interaction. Cell, 144:282-295, 2011
 
9) Catterall, W. A. et al.:International Union of Pharmacology. XL VII. Nomenclature and structurefunction relationships of voltage-gated sodium channels. Pharmacol. Rev., 57:397-409, 2005
 
10) Catterall, W. A.:Voltage-gated sodium channels at 60:structure, function, and pathophysiology. J.Physiol., 590:2577-2589, 2012
PubMed
11) Lai, H. C. & Jan, L. Y.:The distribution and targeting of neuronal voltage-gated ion channels.Nat. Rev. Neurosci., 7:548-562, 2006
PubMed
12) Gutman, G. A. et al.:International Union of Pharmacology. L III. Nomenclature and molecular relationships of voltage-gated potassium channels.Pharmacol. Rev., 57:473-508, 2005
 
13) Jiang, Y. et al.:X-ray structure of a voltagedependent K+ channel. Nature, 423:33-41, 2003
 
14) Jiang, Y. et al.:The principle of gating charge movement in a voltage-dependent K+ channel.Nature, 423:42-48, 2003
 
15) Long, S. B. et al.:Crystal structure of a mammalian voltage-dependent Shaker family K+ channel.Science, 309:897-903, 2005
PubMed
16) Starace, D. M. & Bezanilla, F.:A proton pore in a potassium channel voltage sensor reveals a focused electric field. Nature, 427:548-553, 2004
 
17) Tombola, F. et al.:How does voltage open an ion channel? Annu. Rev. Cell Dev. Biol., 22:23-52,2006
PubMed
P.199 掲載の参考文献
1) Green, T. et al.:Molecular neurobiology and genetics:investigation of neural function and dysfunction. Neuron, 20:427-444, 1998
PubMed
2) Changeux, J.-P. & Edelstein, S. J.:Allosteric receptors after 30 years. Neuron, 21:959-980, 1998
PubMed
3) Novere, N. L. & Changeux, J.-P.:The ligand gatedion channel database. Nucl. Acids Res., 27:340-342, 1999
 
4) Traynelis, S. F. et al.:Glutamate receptor ion channels:structure, regulation, and function.Pharmacol. Rev., 62:405-496, 2010
PubMed
5) Collingridge, G. L. et al.:A nomenclature for ligand-gated ion channels. Neuropharmacology,56:2-5, 2009
PubMed
6) Uemura, T. et al.:Trans-synaptic interaction of GluR δ2 and neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell, 141:1068-1079, 2010
 
7) Sine, S. M. et al.:On the origin of ion selectivity in the Cys-loop receptor family. J. Mol. Neurosci., 40:70-76, 2010
PubMed
8) Sine, S. M. & Engel, A. G.:Recent advances in Cysloop receptor structure and function. Nature, 440:448-455, 2006
PubMed
9) Lukas, R. J. et al.:International union of pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits.Pharmacol. Rev., 51:397-401, 1999
PubMed
10) Olsen, R. W. & Sieghart, W.:International union of pharmacology. LXX. Subtypes of γ-aminobutyric acidA receptors:classification on the basis of subunit composition, pharmacology, and function.Update. Pharmacol. Rev., 60:243-260, 2008
 
11) Webb, T. I. & Lynch, J. W.:Molecular pharmacology of the glycine receptor chloride channel. Curr.Pharm. Des., 13:2350-2367, 2007
PubMed
12) Barnes, N. M. et al.:The 5-HT3 receptor-the relationship between structure and function.Neuropharmacology, 56:273-284, 2009
PubMed
13) Davies, P. A. et al.:A novel class of ligand-gatedion channel is activated by Zn2 +. J. Biol. Chem.,278:712-717, 2003
 
14) Jarvis, M. F. & Khakh, B. S.:ATP-gated P2X cation-channels. Neuropharmacology, 56:208-215, 2009
PubMed
15) Nakanishi, S. et al.:Glutamate receptors:brain function and signal transduction. Brain Res. Rev.,26:230-235, 1998
PubMed
16) Billinton, A. et al.:Advances in the molecular understanding og GABA receptors. Trends Neurosci., 24:277-282, 2001
 
17) Civelli, O. et al.:Molecular diversity of the dopamine receptors. Annu. Rev. Pharmacol. Toxicol., 32:281-307, 1993
 
18) Rohrer, D. K. & Kobilka, B. K.:Insights from in vivo modification of adrenergic receptor gene expression.Annu. Rev. Pharmacol. Toxicol., 38:351-373, 1998
PubMed
19) Sodhi, M. S. & Sanders-Bush, E.:Serotonin and brain development. Int. Rev. Neurobiol., 59:111-174, 2004
PubMed
20) Caulfield, M. P. & Birdsall, N. J. M.:International union of pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharm. Rev.,50:279-290, 1998
 
21) Lazarowski, E. R. et al.:Mechanisms of release of nucleotides and integration of their action as P2Xand P2Y-receptor activating molecules. Mol. Pharm.,64:785-795, 2003
 
22) Civelli, O. et al.:Novel neurotransmitters as natural ligands of orphan G-protein coupled receptors.Trends Neurosci., 24:230-237, 2001
PubMed
P.205 掲載の参考文献
1) Huang, E. J. & Reichardt, L. F.:Trk receptors:roles in neuronal signal transduction. Annu. Rev.Biochem., 72:609-642, 2003
PubMed
2) Lewin, G. R. & Barde, Y. A.:Physiology of the neurotrophins. Annu. Rev. Neurosci., 19:289-317,1996
 
3) Huang, E. J. & Reichardt, L. F.:Neurotrophins:roles in neuronal development and function. Annu.Rev. Neurosci., 24:677-736, 2001
PubMed
4) Barker, P. A.:Whither proBDNF? Nat. Neurosci., 12:105-106, 2009
PubMed
5) Thoenen, H. & Sendtner, M.:Neurotrophins:from enthusiastic expectations through sobering experiences to rational therapeutic approaches. Nat.Neurosci., 5:1046-1050, 2002
PubMed
6) Nawa, H. & Takei, N.:BDNF as an anterophin;a novel neurotrophic relationship between brain neurons. Trends Neurosci., 24:683-685, 2001
PubMed
7) 武井延之, 那波宏之: ニューロトロフィンによる脳機能の調節-細胞応答から行動変容まで. 生化学, 76: 111-123, 2004
 
8) Watanabe, Y. et al.:Cytokine hypothesis of schizophrenia pathogenesis:evidence from human studies and animal models. Psychiatry Clin.Neurosci., 64:217-230, 2010
PubMed
9) 那波宏之, 他: 神経栄養因子とサイトカインの統合失調症への関与. 日本臨床, 61: 521-528, 2003
Medical*Online
10) Castren, E. et al.:Role of neurotrophic factors in depression. Curr. Opin. Pharmacol., 7:18-21, 2007
PubMed

第6章 脳の高次機能

P.217 掲載の参考文献
1) Ecker, J. L. et al.:Melanopsin-expressing retinal ganglion-cell photoreceptors:cellular diversity and role in pattern vision. Neuron, 67:49-60, 2010
PubMed
2) Guillery, R. W. & Sherman, S. M.:Thalamic relay functions and their role in corticocortical communication:generalizations from the visual system. Neuron, 33:163-175, 2002
PubMed
3) Felleman, D. J. & Van Essen D. C.:Distributed hierarchical processing in the primate cerebral cortex. Cereb. Cortex, 1:1-47, 1991
PubMed
4) Casile, A. et al.:The mirror neuron system:a fresh view. Neuroscientist, 17:524-538, 2011
PubMed
P.227 掲載の参考文献
1) 『Principles of Neural Science, Fourth Edition.』 (Kandal, E. R. et. al),McGraw-Hill Medical, 2000
 
2) Hibino, H. et al.:How is the highly positive endocochlear potential formed ? The specific architecture of the stria vascularis and the roles of the ion-transport apparatus., Pflugers Arch., 459:521-533, 2010
 
3) Martin, P. et al.:Negative hair-bundle stiffness betrays a mechanism for mechanical amplification by the hair cell., Proc. Natl. Acad. Sci. USA, 97:12026-12031, 2000
PubMed
4) Chan, D. K. & Hudspeth, A. J.:Ca2 + current-driven nonlinear amplification by the mammalian cochlea in vitro., Nat. Neurosci., 8:149-155, 2005
PubMed
5) Liberman, M. C. et al.:Prestin is required for electromotility of the outer hair cell and for the cochlear amplifier., Nature, 419:300-304, 2002
PubMed
6) 『図説中枢神経系 第二版』(Nieuwenhuys, R. 他/著, 水野 昇, 他/訳), 医学書院, 1991
 
7) 『聴覚・触覚・前庭感覚』(内川惠二/編), 朝倉書店, 2007
 
8) 『標準生理学 第7版』(小澤瀞司, 他/編), 医学書院, 2009
 
9) 『ガイトン生理学 原著11版』(C. G. Arthur, 他/著, 御手洗玄洋, 他/訳), エルゼビア・ジャパン, 2010
 
10) Katsuki, Y. et al.:Electric responses of auditory neurons in cat to soung stimulation., J.Neurophysiol., 21:569-588, 1958
 
11) Pollak, G. D. et al.:The dominance of inhibition in the inferior colliculus., Hear. Res., 274:27-39, 2011
PubMed
12) Wersinger, E. & Fuchs, P. A.:Modulation of hair cell efferents., Hear. Res., 279:1-12, 2011
PubMed
13) 『聴覚・ことば(キーワード心理学シリーズ2巻)』(重野 純/著), 新曜社, 2006
 
14) Grothe, B. et al.:Mechanisms of sound localization in mammals., Physiol. Rev., 90:983-1012, 2010
PubMed
15) Jeffress, L. A.:A place theory of sound localization.,J. Comp. Physiol. Psychol., 41:35-39, 1948
PubMed
16) Oviedo, H. V. et al.:The functional asymmetry of auditory cortex is reflected in the organization of local cortical circuits., Nat. Neurosci., 13:1413-1420, 2010
PubMed
17) Kaas, J. H. & Hackett, T. A.:Subdivisions of auditory cortex and processing streams in primates., Proc. Natl. Acad. Sci. USA, 97:11793-11799, 2000
PubMed
18) 小島久幸: 聴覚皮質の神経経路. 日本音響学会誌, 53: 383-391, 1997
 
19) 高橋宏知: 聴皮質の情報処理. 日本音響学会誌, 67: 119-124, 2011
 
20) 『ピクルス聴覚生理学』(Pickles, J. O. /著. 堀川順生, 他/訳), 二瓶社, 1995
 
21) Malhotra, S. et al.:Sound localization deficits during reversible deactivation of primary auditory cortex and/or dorsal zone., J. Neurophysiol., 99:1628-1642, 2008
 
22)『An atlas of structures, sections, and system』(Haines, D. E.),Urban & Schwarzengerg, 1983
 
P.228 掲載の参考文献
・『聴覚モデル(音響サイエンスシリーズ3) 』(森 周司, 香田 徹/編. 日比野 浩, 他/著), コロナ社, 2011
 
・『The Auditory cortex』(Winer, J. A.& Schreiner, C. E. /ed.),Springer, 2011
 
・『聴覚生理学への道』(勝木保次/著), 紀伊國屋書店, 1967
 
P.234 掲載の参考文献
1) 山本一彦: 抗原の侵入と提示. 『岩波講座 現代医学の基礎8: 免疫と血液の科学』, 岩波書店, 1999
 
2) Singh, P. B.:Chemosensation and genetic individuality. Reproduction, 121:529-539, 2001
PubMed
3) Leinders-Zufall, T. et al.:MHC class I peptides as chemosensory signals in the vomeronasal organ.Science, 306:1033-1037, 2004
PubMed
4) Novotny, M. V.:Pheromones, binding proteins and receptor responses in rodents. Biochem. Soc. Trans.,31:117-122, 2003
PubMed
5) Hurst, J. L. & Beynon, R. J.:Scent wars:the chemobiology of competitive signalling in mice.Bioessays, 26:1288-1298, 2004
PubMed
6) Kimoto, H. et al.:Sex-specific peptides from exocrine glands stimulate mouse vomeronasal sensory neurons. Nature, 437:898-901, 2005
PubMed
7) Haga, S. et al.:The male mouse pheromone ESP1 enhances female sexual receptive behaviour through a specific vomeronasal receptor. Nature, 466:118-122, 2010
PubMed
8) 椛 秀人: フェロモン情報処理と学習制御. 実験医学, 21: 2413-2419, 2003
Medical*Online
9) Kaba, H.:Neurobiology of mammalian olfactory learning that occurs during sensitive periods. Curr.Zool., 56:819-833, 2010
 
P.240 掲載の参考文献
1) Pearson, K.:The control of walking. Sci. Am., 235:72-86, 1976
PubMed
2) Kitsukawa, T. et al.:A novel instrumented multipeg running wheel system, Step-Wheel, for monitoring and controlling complex sequential stepping in mice.J. Neurophysiol., 106:479-487, 2011
PubMed
3) Sato, Y. et al.:Gait modification during approach phase when stepping over an obstacle in rats.Neurosci. Res., 72:263-269, 2012
PubMed
4) Grillner, S. & Wallen, P.:Central pattern generators for locomotion, with special reference to vertebrates.Annu. Rev. Neurosci., 8:233-261, 1985
PubMed
5) 『Neural Control of Locomotion』(Orlovsky, G. N. et al.). Oxford University Press, 1999
 
6) Fortier, P. A. et al.:Locomotor deficits in the mutant mouse, Lurcher. Exp. Brain Res., 66:271-286, 1987
PubMed
7) Ichise, T. et al.:mGluR1 in cerebellar Purkinje cells essential for long-term depression, synapse elimination and motor coordination. Science, 288:1832-1835, 2000
PubMed
8) English, A. W.:Interlimb coordination during locomotion. Amer. Zool., 29:255-266, 1989
 
9) Yanagihara, D. & Kondo, I.:Nitric oxide plays a key role in adaptive control of locomotion in cat. Proc.Natl. Acad. Sci. USA, 93:13292-13297, 1996
 
10) Ito, S. et al.:A mathematical model of adaptive behavior in quadruped locomotion. Biol. Cybern.,78:337-347, 1998
PubMed
11) 伊藤 聡, 他: 環境の変化に適応する四足歩行ロボットシステム. 日本ロボット学会誌, 17: 595-603, 1999
 
12)Yanagihara, D.:Mechanisms of locomotor control in the cerebellum. Brain Nerve, 62:1149-1156, 2010
PubMed
P.247 掲載の参考文献
1) Iversen, S. et al.:Emotional states and feelings.『Principles of Neural Science』( Kandel, E. R. et al./ed.), pp982-997, Mcgraw-Hill, 2000
 
2)『The Emotional Brain』(LeDoux, J. E.), Simon & Schuster, 1996
 
3) LeDoux, J. E.:Emotion, memory and the brain. Scientific American, 270:50-57, 1994
PubMed
4) Davis, M.:The role of the amygdala in fear and anxiety. Annual. Rev. Neurosci., 15:353-375, 1992
 
5) Siegel, A. et al.:Neuropharmacology of brain-stimulation-evoked aggression. Neurosci. Biobehav.Rev., 23:359-389, 1999
PubMed
6) Ogawa, S. et al.:Abolition of male sexual behaviors in mice lacking estrogen receptors α and β ( αβERKO). Proc. Natl. Acad. Sci. USA, 97:14737-14741,2000
 
7) 小川園子: 行動の制御にかかわる脳内エストロゲン受容体の役割. 『生体統御システムと内分泌撹乱』(井上 達, 井口泰泉/編), pp189-200, シュプリンガー・フェアラーク東京, 2005
 
8) Ogawa, S. et al.:Differential roles of two types of estrogen receptors in the regulation of aggressive behaviors in mice.『Biology of aggression』( Nelson,R./ed.), pp231-249, Oxford University Press, 2006
 
9) 佐久間康夫: 性行動. 『現代の神経内分泌学』(吉田 尚/監訳), pp281-289, メディカル・サイエンス・インターナショナル, 1996
 
10) Pfaff, D. W. et al.:Cellular and molecular mechanisms of female reproductive behaviors.『 The Physiology of Reproduction』( Knobil, E. & Neill, J. D. /ed.) vol. 2,pp107-220, Raven Press, 1994
 
11) Meisel, R. L. & Sachs, B. D.:The physiology of male sexual behavior. 『The Physiology of Reproduction』(Knobil, E. & Neill, J. D. /ed.) vol. 2, pp1-106, Raven Press, 1994
 
12) 山内兄人, 佐藤元康: 性行動制御機構とその性分化における性ホルモンの役割. 神経研究の進歩, 42: 610-623, 1998
 
13) Sano, K. et al.:Differential effects of site-specificknockdown of estrogen receptor a in the medial amygdala, medial preoptic area, and ventromedial nucleus of the hypothalamus on sexual and aggressive behavior of male mice. Eur. J. Neurosci., 2013, in press
 
P.257 掲載の参考文献
1) Dubnau, J. & Tully, T.:Gene discovery in Drosophila:new insights for learning and memory. Annu. Rev.Neurosci., 21:407-444, 1998
PubMed
2) 遠藤昌吾: 無脊椎動物アメフラシのシナプス可塑性. 『運動の神経科学』(西野仁雄, 柳原 大/編), pp145-156, ナップ, 2000
 
3) Byrne, J. H.:Cellular analysis of associative learning. Physiol. Rev., 67:329-439, 1987
PubMed
4) Scoville, W. B. & Milner, B.:Loss of recent memory after bilateral hippocampal lesions. J. Neurol.Neurosurg. Psychiat., 20:11-21, 1957
PubMed
5) Huppert, F. A. & Piercy, M.:Dissociation between learning and remembering in organic amnesia.Nature, 275:317-318, 1978
PubMed
6) Huppert, F. A. & Piercy, M.:Normal and abnormal forgetting in organic amnesia:effect of locus of lesion. Cortex, 15:385-390, 1979
PubMed
7) 『Memory and Brain』(Squire, L. R.), Oxford University Press, 1987
 
8) 二木宏明: 前頭前野と記憶. 生体の科学, 47: 50-53, 1996
 
9) 伊藤正男: 小脳と運動調節. 新医科学体系, 7: 273-283, 1995
 
10) Holmes, G.:The cerebellum of man. Brain, 62:1-30, 1939
 
11) 『脳と記憶』(二木宏明/著), 共立出版, 1989
 
12) Milner, B. et al.:Cognitive neuroscience and the study of memory. Neuron, 20:445-468, 1998
 
13) Mayford, M. & Kandel, E. R.:Genetic approaches to memory storage. Trends Genet., 15:463-470, 1999
PubMed
14) Liu, X. et al:Optogenetic stimulation of a hippocampal engram activates fear memory recall. Nature, 484:381-385, 2012
PubMed
P.265 掲載の参考文献
1) Purcell, S. M. et al.:Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature, 460:748-752, 2009
PubMed
2) Stefansson, H. et al.:Common variants conferring risk of schizophrenia. Nature, 460:744-747, 2009
PubMed
3) Shi, J. et al.:Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature, 460:753-757, 2009
PubMed
4) Egan, M. F. et al.:The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell,112:257-269, 2003
PubMed
5) Hariri, A. R. et al.:Brain-derived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance. J. Neurosci., 23:6690-6694,2003
PubMed
6) Weaver, I. C. et al.:Epigenetic programming by maternal behavior. Nat. Neurosci., 7:847-854,2004
PubMed
7) Plomin, R. et al.:The genetic basis of complex human behaviors. Science, 264:1733-1739, 1994
PubMed
8) Crabtree, G. R.:Our fragile intellect. Part I. Trends Genet., 29:1-3, 2013
 
9) Takao, K. et al.:Impact of brain-behavior phenotypying of genetically-engineered mice on research of neuropsychiatric disorders. Neurosci. Res., 58:124-132, 2007
PubMed
10) Kuroda, K. et al.:Behavioral alterations associated with targeted disruption of exons 2 and 3 of the Disc1 gene in the mouse. Hum. Mol. Genet., 20:4666-4683, 2011
PubMed
11) Koike, H. et al.:Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice. Proc. Natl. Acad. Sci. USA, 103:3693-3697, 2006
PubMed
12) Hikida, T. et al.:Dominant-negative DISC1 transgenicmice display schizophrenia associated phenotypes detected by measures translatable to humans. Proc.Natl. Acad. Sci. USA, 104:14501-14506, 2007
 
13) Li, W. et al.:Specific developmental disruption of disrupted-in-schizophrenia-1 function results in schizophrenia-related phenotypes in mice. Proc.Natl. Acad. Sci. USA, 104:18280-18285, 2007
PubMed
14) Pletnikov, M. V. et al.:Inducible expression of mutant human DISC1 in mice is associated with brain and behavioral abnormalities reminiscent of schizophrenia. Mol. Psychiatry, 13:173-86, 115,2008
PubMed
15) Zeng, H. et al.:Forebrain-specific calcineurin knockout selectively impairs bidirectional synaptic plasticity and working/episodic-like memory. Cell, 107:617-629, 2001
PubMed
16) Miyakawa, T. et al.:Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. USA, 100:8987-8992, 2003
PubMed
17) Frankland, P. W. et al.:Alpha-CaMKII-dependent plasticity in the cortex is required for permanent memory. Nature, 411:309-313, 2001
PubMed
18) Yamasaki, N. et al.:Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol. Brain, 1:6, 2008
PubMed
19) Takao, K. et al.:Deficiency of Schnurri-2, an MHCenhancer binding protein, induces mild chronicinflammation in the brain and confers molecular,neuronal, and behavioral phenotypes related tochizophrenia. Neuropsychopharmacology. in press
 
20) Mohn, A. R. et al.:Mice with reduced NMDA receptor expression display behaviors related to schizophrenia.Cell, 98:427-436, 1999
PubMed
21) Duncan, G. E. et al.:Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav. Brain Res.,153:507-519, 2004
 
22) Duncan, G. E. et al.:Effects of haloperidol, clozapine,and quetiapine on sensorimotor gating in a geneticmodel of reduced NMDA receptor function.Psychopharmacology(Berl), 184:190-200, 2006
 
23) Duncan, G. E. et al.:Typical and atypical antipsychotic drug effects on locomotor hyperactivity and deficits in sensorimotor gating in a genetic model of NMDAeceptor hypofunction. Pharmacol. Biochem. Behav.,85:481-491, 2006
 
24) Dzirasa, K. et al.:Hyperdopaminergia and NMDAeceptor hypofunction disrupt neural phaseignaling. J. Neurosci., 29:8215-8224, 2009
PubMed
25) Halene, T. B. et al.:Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model forchizophrenia. Genes. Brain. Behav., 8:661-675,2009
 
26) Du, X. et al.:Heterozygous deletion of NR1 subunitf the NMDA receptor alters ethanol-relatedehaviors and regional expression of NR2 subunitsn the brain. Neurotoxicol. Teratol., 34:177-186,2012
PubMed
27) Hattori, S. et al.:Behavioral abnormalities andopamine reductions in sdy mutant mice with aeletion in Dtnbp1, a susceptibility gene forchizophrenia. Biochem. Biophys. Res. Commun.,373:298-302, 2008
PubMed
28) Takao, K. et al.:Impaired long-term memoryetention and working memory in sdy mutant miceith a deletion in Dtnbp1, a susceptibility gene forchizophrenia. Mol. Brain, 1:11, 2008
PubMed
29) Jentsch, J. D. et al.:Dysbindin modulates prefrontalortical glutamatergic circuits and working memoryunction in mice. Neuropsychopharmacology, 34:2601-2608, 2009
PubMed
30) Gogos, J. A. et al.:Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes inatecholamine levels and behavior. Proc. Natl. Acad.ci. USA, 95:9991-9996, 1998
 
31) Haasio, K. et al.:Tissue histopathology, clinical chemistry and behaviour of adult Comt-gene-disruptedice. J. Appl. Toxicol., 23:213-219, 2003
PubMed
32) Papaleo, F. et al.:Genetic dissection of the role ofatechol-O-methyltransferase in cognition and stresseactivity in mice. J. Neurosci., 28:8709-8723,2008
PubMed
33) Tammimaki, A. et al.:Increase in free choice oral ethanol self-administration in catechol-o-methyltransferase gene-disrupted male mice. Basiclin. Pharmacol. Toxicol., 103:297-304, 2008
PubMed
34) Lai, W. S. et al.:Akt1 deficiency affects neuronalorphology and predisposes to abnormalities inrefrontal cortex functioning. Proc. Natl. Acad. Sci.SA, 103:16906-16911, 2006
 
35) Emamian, E. S. et al.:Convergent evidence formpaired AKT1-GSK3beta signaling in schizophrenia.at. Genet., 36:131-137, 2004
PubMed
36) Chen, Y. W. & Lai, W. S.:Behavioral phenotyping of-akt murine thymoma viral oncogene homology-eficient mice reveals a sex-specific prepulsenhibition deficit in females that can be partiallylleviated by glycogen synthase kinase-3 inhibitorsut not by antipsychotics. Neuroscience, 174:178-189, 2011
 
37) Yu, H. et al.:Variant brain-derived neurotrophicactor Val66Met polymorphism alters vulnerability totress and response to antidepressants. J. Neurosci.,32:4092-4101, 2012
PubMed
38) Chen, Z. Y. et al.:Genetic variant BDNF(Val66Met)olymorphism alters anxiety-related behavior.cience, 314:140-143, 2006
 
39) Soliman, F. et al.:A genetic variant BDNF polymorphismlters extinction learning in both mouse and human.cience, 327:863-866, 2010
 
40) Savelieva, K. V. et al.:Genetic disruption of bothryptophan hydroxylase genes dramatically reduces serotonin and affects behavior in models sensitive tontidepressants. PLoS One, 3:e3301, 2008
PubMed
41) Holmes, A. et al.:Mice lacking the serotoninransporter exhibit 5-HT(1A)receptor-mediated abnormalities in tests for anxiety-like behavior.europsychopharmacology, 28:2077-2088, 2003
 
42) Holmes, A. et al.:Reduced aggression in mice lackinghe serotonin transporter. Psychopharmacology(Berl),161:160-167, 2002
PubMed
43) Holmes, A. et al.:Abnormal anxiety-related behavior in serotonin transporter null mutant mice:thenfluence of genetic background. Genes. Brain.ehav., 2:365-380, 2003
 
44) Holmes, A. et al.:Evaluation of antidepressantrelated behavioral responses in mice lacking theerotonin transporter. Neuropsychopharmacology,27:914-923, 2002
PubMed
45) Line, S. J. et al.:Opposing alterations in anxiety and species-typical behaviours in serotoninransporter overexpressor and knockout mice. Eur.europsychopharmacol., 21:108-116, 2011
PubMed
46) Zhao, S. et al.:Insertion mutation at the C-terminus of the serotonin transporter disrupts brain serotonin function and emotion-related behaviors in mice.euroscience, 140:321-334, 200
 
47) Shen, Q. et al.:gamma-Aminobutyric acid-type A receptor deficits cause hypothalamic-pituitaryadrenalxis hyperactivity and antidepressant drugensitivity reminiscent of melancholic forms ofepression. Biol. Psychiatry, 68:512-520, 2010
PubMed
48) Earnheart, J. C. et al.:GABAergic control of adultippocampal neurogenesis in relation to behavior indicative of trait anxiety and depression states. J.eurosci., 27:3845-3854, 2007
 
49) Crestani, F. et al.:Decreased GABAA-receptor lustering results in enhanced anxiety and a bias for threat cues. Nat. Neurosci., 2:833-839, 1999
 
50) Blednov, Y. A. et al.:GABAA receptor alpha 1 andeta 2 subunit null mutant mice:behavioral responseso ethanol. J. Pharmacol. Exp. Ther., 305:854-863,2003
 
51) Haller, J. et al.:The effects of genetic and pharmacological lockade of the CB1 cannabinoid receptorn anxiety. Eur. J. Neurosci., 16:1395-1398, 2002
 
52) Maccarrone, M. et al.:Age-related changes of nandamide metabolism in CB1 cannabinoid receptor knockout mice:correlation with behaviour.ur. J. Neurosci., 15:1178-1186, 2002
 
53) Martin, M. et al.:Involvement of CB1 cannabinoid receptors in emotional behaviour. Psychopharmacology (Berl), 159:379-387, 2002
PubMed
54) Uriguen, L. et al.:Impaired action of anxiolyticrugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology, 46:966-973, 2004
PubMed
55) Aso, E. et al.:BDNF impairment in the hippocampuss related to enhanced despair behavior in CB1 knockout mice. J. Neurochem., 105:565-572, 2008
 
56) Varvel, S. A. & Lichtman, A. H.:Evaluation of CB1 receptor knockout mice in the Morris water maze. J.harmacol. Exp. Ther., 301:915-924, 2002
PubMed
57) Bilkei-Gorzo, A. et al.:Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proc. Natl. Acad. Sci. USA, 102:15670-15675, 2005
PubMed
58) Hungund, B. L. et al.:Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-inducedopamine release in the nucleus accumbens. J.eurochem., 84:698-704, 2003
 
59) Poncelet, M. et al.:Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice.eurosci. Lett., 343:216-218, 2003
PubMed
60) Wei, Q. et al.:Glucocorticoid receptor overexpression in forebrain:a mouse model of increased emotionalability. Proc. Natl. Acad. Sci. USA, 101:11851-11856, 2004
PubMed
61) Wei, Q. et al.:Overexpressing the glucocorticoid receptor in forebrain causes an aging-like neuro endocrine phenotype and mild cognitive dysfunction.. Neurosci., 27:8836-8844, 2007
 
62) Smith, G. W. et al.:Corticotropin releasing factor receptor 1-deficient mice display decreased anxiety, impared stress response, and aberrant neuroendocrine development. Neuron, 20:1093-1102, 1998
 
63) Timpl, P. et al.:Impaired stress response and reduced anxiety in mice lacking a functional corticotropin releasing hormone receptor 1. Nat. Genet., 19:162-166, 1998
 
64) Sillaber, I. et al.:Enhanced and delayed stress induced alcohol drinking in mice lacking functional RH1 receptors. Science, 296:931-933, 2002
 
65) Miller, M. B. et al.:Limbic corticotropin-releasing hormone receptor 1 mediates anxiety-related behavior and hormonal adaptation to stress. Nat.eurosci., 6:1100-1107, 2003
 
66) McClung, C. A. et al.:Regulation of dopaminergic transmission and cocaine reward by the Clock gene.roc. Natl. Acad. Sci. USA, 102:9377-9381, 2005
 
67) Roybal, K. et al.:Mania-like behavior induced by disruption of CLOCK. Proc. Natl. Acad. Sci. USA,104:6406-6411, 2007
PubMed
68) Engel, S. R.:The extra cellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol. Psychiatry,14:448-461,2008
 
69) Shaltiel, G. et al.:Evidence for the involvement of the kainate receptor subunit GluR6(GRIK2)in mediating behavioral displays related to behavioralymptoms of mania. Mol. Psychiatry, 13:858-872,2008
PubMed
70) Prickaerts, J. et al.:Transgenic mice overexpressing glycogen synthase kinase 3beta:a putative model of hyperactivity and mania. J. Neurosci., 26:9022-9029, 2006
 
71) Kasahara, T. et al.:Mice with neuron-specific accumulation of mitochondrial DNA mutations showood disorder-like phenotypes. Mol. Psychiatry,11:577-93, 523, 2006
PubMed
72) Nakatani, J. et al.:Abnormal behavior in a chromosome engineered mouse model for human 15q11-13 duplication seen in autism. Cell, 137:1235-1246,2009
 
73) Tabuchi, K. et al.:A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmissionn mice. Science, 318:71-76, 2007
PubMed
74) Sadakata, T. et al.:Reduced axonal localization of aaps2 splice variant impairs axonal release of BDNFnd causes autistic-like behavior in mice. Proc. Natl.cad. Sci. USA, 109:21104-21109, 2012
 
75) Peca, J. et al.:Shank3 mutant mice display autistic like behaviours and striatal dysfunction. Nature,472:437-442, 2011
PubMed
76) Wong, P. et al.:Pregnenolone rescues schizophrenia like behavior in dopamine transporter knockout mice. PLoS One, 7:e51455, 2012
PubMed
77) Gainetdinov, R. R. et al.:Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science, 283:397-401, 1999
PubMed
78) Giros, B. et al.:Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379:606-612, 1996
PubMed
79) Won, H.:GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice. Nat. Med.,17:566-572, 2011
PubMed
80) Schmalzigaug, R. et al.:Impaired fear response in mice lacking GIT1. Neurosci. Lett., 458:79-83,
PubMed
・『What's Wrong With My Mouse ? -Behavioral Phenotyping of Transgenic and Knockout Mice 2nd edition』(Crawley, J. N.), Wiley-Liss, 2007
 
P.268 掲載の参考文献
・高雄啓三, 宮川 剛: マウスで行動遺伝学. 『研究をささえるモデル生物』(吉川 寛, 堀 寛/編), pp42-44, 化学同人, 2009
 
P.276 掲載の参考文献
1) Dronkers, N. F. et al.:Language and the aphasias. Principles of neural science (Kandel, E. R.), McGraw-Hill, pp1169-1187, 2000
 
2) Ryan, A. & Miller, J.:Single unit responses in the inferior colliculus of the awake and performing rhesus monkey. Exp. Brain Res., 32:389-407, 1978
 
3) Pfingst, B. E. & O'Connor, T. A.:Characteristics of neurons in auditory cortex of monkeys performing a simple auditory task. J. Neurophysiol., 45:16-34,1981
PubMed
4) Elberling, C. et al.:Auditory magnetic fields from the human cortex. Influence of stimulus intensity.cand. Audiol., 10:203-207, 1981
 
5) Soeta, Y. & Nakagawa, S.:Auditory evokedesponses in human auditory cortex to the variation pf sound intensity in an ongoing tone. Hear. Res.,287:67-75, 2012
 
6) Elberling, C. et al.:Auditory magnetic fields:source location and 'tonotopical organization' in the right hemisphere of the human brain. Scand. Audiol.,11:61-65, 1982
PubMed
7) Romani, G. L. et al.:Tonotopic organization of the human auditory cortex. Science, 216:1339-1340,1982
PubMed
8) Lauter, J. L. et al.:Tonotopic organization in human auditory cortex revealed by positron emission tomography. Hear. Res., 20:199-205, 1985
PubMed
9) Humphries, C. et al.:Tonotopic organization of human auditory cortex. Neuroimage, 50:1202-1211, 2010
PubMed
10) Hirano, S. et al.:Cortical activation by monaural speech sound stimulation demonstrated by positron emission tomography. Exp. Brain Res., 113:75-80,1997
PubMed
11) Crinion, J. T. et al.:Temporal lobe regions engaged during normal speech comprehension. Brain, 126:1193-1201, 2003
PubMed
12) Kojima, H. et al.:The role of the temporal coding system in the auditory cortex on speech recognition.euro Report, 8:2395-2398, 1997
 
13) Laird, A. R. et al.:ALE meta-analysis:controlling the false discovery rate and performing statistical contrasts. Hum. Brain Mapp., 25:155-164, 2005
PubMed
14) Turkeltaub, P. E. & Coslett, H. B.:Localization of sublexical speech perception components. Brain Lang., 114:1-15, 2010
PubMed
15) Binder, J. R. et al.:Where is the semantic system? A critical review and meta-analysis of 120 functional neuroimaging studies. Cereb. Cortex, 19:2767-2796, 2009
 
16) Damasio, H. et al.:Neural systems behind word and concept retrieval. Cognition, 92:179-229, 2004
 
17) Binder, J. R. et al.:Where is the semantic system? A critical review and meta-analysis of 120 functional neuroimaging studies. Cereb. Cortex, 19:2767-2796, 2009
 
18) Tateya, I. et al.:Inner ear hearing loss modulates ipsilateral temporal lobe activation by monaural speech stimuli. Neuroreport, 14:763-767, 2003
PubMed
19) Naito, Y. et al.:Increased cortical activation during hearing of speech in cochlear implant users. Hear.Res., 143:139-146, 2000
PubMed
20) Roland, P. E.:Chapter 9 Language.『 Brain activation』 (Roland, P. E. /ed.), Wiley-Liss, pp269-290, 1993
 
21) Naito, Y. et al.:Sound-induced activation of auditory cortices in cochlear implant users with post-and prelingual deafness demonstrated by positron emission tomography. Acta Otolaryngol.,117:490-496, 1997
PubMed
22) Fujiwara, K. et al.:Brain metabolism of children with profound deafness:a visual language activation study by 18F-fluorodeoxyglucose positron emissionomography. Acta Otolaryngol., 128:393-397, 2008
PubMed

第7章 神経・精神疾患の分子機構

P.286 掲載の参考文献
1) Howes, O. D. & Kapur, S.:The dopamine hypothesis of schizophrenia:version III-the final common pathway. Schizophr. Bull., 35:549-562, 2009
PubMed
2) Javitt, D. C. et al.:Has an angel shown the way? etiological and therapeutic implications of the PCP/MDA model of schizophrenia. Schizophr. Bull.,38:958-966, 2012
 
3) Laruelle, M. et al.:Mechanism of action of antipsychotic drugs:from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin. Ther., 27:S16-24, 2005
PubMed
4) Lewis, D. A.:Cortical circuit dysfunction and cognitive feficits in schizophrenia--implications for preemptive interventions. Eur. J. Neurosci., 35:1871-1878,2012
PubMed
5) Meltzer, H. Y. et al.:Serotonin receptors:their key role in drugstotre at schizophrenia. Prog.europsychopharmacol. Biol. Psychiatry, 27:1159-1172, 2003
PubMed
6) Nishikawa, T.:Analysis of free D-serine in mammals snd its biological relevance. J. Chromatogr. B Analyt.Technol. Biomed. Life Sci., 879:3169-3183, 2011
 
7) 山本直樹, 他: ドーパミン・興奮性アミノ酸仮説. 『統合失調症の治療-臨床と基礎-』(佐藤光源, 他/編), pp38-54, 朝倉書店, 2007
 
8) van Os, J. & Kapur, S.:Schizophrenia. Lancet,374:635-645, 2009
PubMed
9) 高橋三郎, 他/訳: 統合失調症および他の精神病性障害. 『DSM-IV-TR-精神疾患の診断・統計マニュアル 新訂版 (DIAGNOSTIC ANDSTATIATICAL MANUAL OF MENTAL DISORDERS, FOURTH EDITION, TEXT REVISION) 』(American Psychiatric Association, 2000), pp291-333, 医学書院, 2003
 
10) Family Studies.『 Schizophrenia Genesis:The Origins of Madness』(Gottesman, I.I.), pp94-103, W.H.reeman & Company, 1991
 
11) 『心の病気と分子生物学-生物学的精神医学の新展開-』(石浦章一, 丸山 敬/訳, Barondes, S. H. /著), p134, 日経サイエンス社, 1994
 
12) ドーパミン. 『神経薬理学: 生化学からのアプローチ』(樋口宗史/監訳, Cooper, J. R. 他/著), pp197-234, メディカル・サイエンス・インターナショナル, 2005
 
13) Seeman, P. et al.:Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261:717-719, 1976
PubMed
14) Malhotra, D. & Sebat, J.:CNVs:harbingers of a rare variant revolution in psychiatric genetics. Cell,148:1223-1241, 2012
PubMed
15) Sullivan, P. F. et al.:Genetic architectures of psychiatric disorders:the emerging picture and itsmplications. Nat. Rev. Genet., 13:537-551, 2012
PubMed
16) Anderson, G. & Maes, M.:Schizophrenia:Linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression. Prog.europsychopharmacol. Biol. Psychiatry, in press
 
17) Bennett, M. R.:Schizophrenia:susceptibility genes,endritic-spine pathology and gray matter loss. Prog.eurobiol., 95:275-300, 2011
 
18) Gottesman, I. I. et al.:The endophenotype concept on psychiatry:etymology and strategic intentions.Am. J. Psychiatry, 160:636-645, 2003
PubMed
19) Javitt, D. C. et al.:Neurophysiological biomarkers for drug development in schizophrenia. Nat. Rev.Drug Discov., 7:68-83, 2008
PubMed
20) Miyakawa, T. et al.:Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. USA, 100:8987-8992, 2003
PubMed
21) Pratt, J. et al.:Advancing schizophrenia drug discovery:optimizing rodent models to bridge the translational gap. Nat. Rev. Drug Discov., 11:560-579, 2012
PubMed
P.292 掲載の参考文献
1) 加藤忠史: 気分障害の動物モデル. 実験医学増刊, 30: 388-393, 2012
 
2) Li, N. et al.:mTOR-dependent synapse formation underlies the rapid antidepressant effects of NMDA antagonists. Science, 329:959-964, 2010
PubMed
3) Snyder, J. S. et al.:Adult hippocampal neurogenesis buffers stress responses and depressive behaviour.Nature, 476:458-461, 2011
PubMed
4) Price, J. L. & Drevets, W. C.:Neural circuits underlying the pathophysiology of mood disorders.Trends Cogn. Sci., 16:61-71, 2012
PubMed
5) Schweighofer, N. et al.:Low-serotonin levels increase delayed reward discounting in humans. J.Neurosci., 28:4528-4532, 2008
PubMed
6) Savitz, J. B. et al.:Habenula volume in bipolar disorder and major depressive disorder:a high resolution magnetic resonance imaging study. Biol.sychiatry, 69:336-343, 2011
 
7) Psychiatric GWAS Consortium Bipolar Disorder Working Group:Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat. Genet., 43:977-983, 2011
 
8) Kupferschmidt, D. A. & Zakzanis, K. K.:Toward aunctional neuroanatomical signature of bipolar disorder:quantitative evidence from the neuroimaging literature. Psychiatry Res., 193:71-79, 2011
PubMed
9) Konradi, C. et al.:Hippocampal interneurons in bipolar disorder. Arch. Gen. Psychiatry, 68:340-350, 2011
PubMed
10) Manji, H. et al.:Impaired mitochondrial function in psychiatric disorders. Nat. Rev. Neurosci., 13:293-307, 2012
PubMed
・『うつ病の脳科学精神科診療の未来を切り拓く』(加藤忠史/著), 幻冬舎, 2009
 
・『双極性障害 第2版-病態の理解から治療戦略まで』(加藤忠史/著), 医学書院, 2011
 
・『動物に「うつ」はあるのか「心の病」がなくなる日』(加藤忠史/著), PHP研究所, 2012
 
P.298 掲載の参考文献
1) Amir, R. E. et al.:Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet., 23:185-188,1999
 
2) Jamain, S. et al.:Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet., 34:27-29,2003
PubMed
3) Durand, C. M. et al.:Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nat.enet., 39:25-27, 2007
 
4) Sanders, S. J. et al.:De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature, 485:237-241, 2012
PubMed
5) O'Roak, B. J. et al.:Sporadic autism exomes reveal highly a interconnected protein network of de novo mutations. Nature, 485:246-250, 2012
PubMed
6) Neale, B. M. et al.:Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature, 485:242-245, 2012
PubMed
7) Yang, M. et al.:Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent Shank3 null mutant mice. J. Neurosci., 32:6525-6541, 2012
PubMed
8) Penagarikano, O. et al.:Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell, 147:235-246,2011
PubMed
9) Kanai, C. et al.:Cognitive profiles of adults with asperger's disorder, high-functioning autism, and pervasive developmental disorder not otherwise specified based on the WAIS-III. Res. Autismpectr. Disord., 6:58-64, 2012
 
10) Nakano, T. et al.:Atypical gaze patterns in children and adults with autism spectrum disorders dissociated from developmental changes in gazeehaviour. Proc. Biol. Sci., 277:2935-2943, 2010
PubMed
11) Nakano, T. et al.:Deficit in visual temporal integration in autism spectrum disorders. Proc. Biol. Sci., 277:1027-1030, 2010
PubMed
12) Nakano, T. et al.:Superior haptic-to-visual shape matching inautism spectrum disorders.Neuropsychologia, 50:696-703, 2012
PubMed
13) Yamasue, H. et al.:Sex-linked neuroanatomical basis of human altruistic cooperativeness. Cereb.Cortex, 18:2331-2340, 2008
PubMed
14) Yamasaki, S. et al.:Reduced gray matter volume of pars opercularis is associated with impaired social communication in high-functioning autism spectrumisorders. Biol. Psychiatry, 68:1141-1147, 2010
PubMed
15) Jin, D. et al.:CD38 is critical for social behaviour by regulating oxytocin secretion. Nature, 446:41-45, 2007
PubMed
16) Kosfeld, M. et al.:Oxtocin increases trust in humans. Nature, 435:673-676, 2005
 
17) Liu, X. et al.:Association of the oxytocin receptor (OXTR)gene polymorphisms with autism spectrum disorder(ASD)in the Japanese population. J. Hum.enet., 55:137-141, 2010
 
18) Sonuga-Barke, E. J.:The dual pathway model of AD/HD:an elaboration of neuro-developmental characteristics. Neurosci. Biobehav. Rev., 27:593-604, 2003
PubMed
19) 曽良一郎, 他: AD/HDの遺伝要因解明の現状. 分子精神医学, 9: 262-267, 2009
Medical*Online
P.309 掲載の参考文献
1) Felbecker, A. et al.:Four familial ALS pedigrees discordant for two SOD1 mutations:are all SOD1 mutations pathogenic? J. Neurol. Neurosurg.sychiatry, 81:572-577, 2010
 
2) Sato, T. et al.:Rapid disease progression correlates with instability of mutant SOD1 in familial ALS.Neurology, 65:1954-1957, 2005
PubMed
3) Yang, Y. et al.:The gene encoding alsin, a protein with three guanine-nucleotide exchange factor domains, is mutated in a form of recessive emyotrophic lateral sclerosis. Nat. Genet., 29:160-165, 2001
 
4) Yamanaka, K. et al.:Unstable mutants in the peripheral endosomal membrane component ALS2 cause early-onset motor neuron disease. Proc. Natl.Acad. Sci. USA, 100:16041-16046, 2003
PubMed
5) Chen, Y. Z. et al.:DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am. J. Hum. Genet., 74:1128-1135, 2004
 
6) Orlacchio, A. et al.:SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain, 133:591-598, 2010
PubMed
7) Wu, D. et al.:Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann. Neurol., 62:609-617, 2007
PubMed
8) Neumann, M. et al.:Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314:130-133, 2006
 
9) Arai, T. et al.:TDP-43 is a component of ubiquitin positive tau-negative inclusions in frontotempora lobar degeneration and amyotrophic lateral sclerosis.Biochem. Biophys. Res. Commun., 351:602-611,2006
PubMed
10) Sreedharan, J. et al.:TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science,319:1668-1672, 2008
PubMed
11) Chow, C. Y. et al.:Deleterious variants of FIG4, a phosphoinositide phosphatase, in patients with ALS.m. J. Hum. Genet., 84:85-88, 2009
 
12) Maruyama, H. et al.:Mutations of optineurin in amyotrophic lateral sclerosis. Nature, 465:223-226,2010
PubMed
13) Swarup, V. et al.:Deregulation of TDP-43 in amyo trophic lateral sclerosis triggers nuclear factor κ B-mediatedathogenic pathways. J. Exp. Med., 208:2429-2447, 2011
 
14) Johnson, J. O. et al.:Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron,68:857-864, 2010
PubMed
15) Deng, H. X. et al.:Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature, 477:211-215, 2011
PubMed
16) Al-Saif, A. et al.:A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann.Neurol., 70:913-919, 2011
 
17) Parkinson, N. et al.:ALS phenotypes with mutations in CHMP2B(charged multivesicular body protein 2B). Neurology, 67:1074-1077, 2006
PubMed
18) Cox, L. E. et al.:Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis(ALS). PLoS One, 5:e9872, 2010
PubMed
19) Wu, C. H. et al.:Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature,488:499-503, 2012
PubMed
20) DeJesus-Hernandez, M. et al.:Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron, 72:245-256, 2011
PubMed
21) Renton, A. E. et al.:A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron, 72:257-268, 2011
PubMed
22) Majounie, E. et al.:Frequency of the C9 or f72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia:a cross-sectional study. Lancet Neurol.,11:323-330, 2012
 
23) Ishiura, H. et al.:C9ORF72 repeat expansion in amyotrophic lateral sclerosis in the Kii peninsula of Japan. Arch. Neurol., 69:1154-1158, 2012
PubMed
24) Rothstein, J. D.:TDP-43 in amyotrophic lateral sclerosis:pathophysiology or patho-babel? Ann.Neurol., 61:382-384, 2007
 
25) Ferraiuolo, L. et al.:Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat.ev. Neurol., 7:616-630, 2011
 
26) Kawahara, Y. et al.:Glutamate receptors:RNA editing and death of motor neurons. Nature, 427:801, 2004
PubMed
27) Hideyama, T. et al.:Induced loss of ADAR2 engenders slow death of motor neurons from Q/R site-unedited GluR2. J. Neurosci., 30:11917-11925,2010
PubMed
28) Igaz, L. M. et al.:Dysregulation of the ALS-associatedene TDP-43 leads to neuronal death and gegeneration in mice. J. Clin. Invest., 121:726-738,2011
 
29) Urushitani, M. et al.:Proteasomal inhibition by misfolded mutant superoxide dismutase 1 induces selective motor neuron death in familial amyotrophic lateral sclerosis. J. Neurochem., 83:1030-1042,2002
PubMed
30) Tashiro, Y. et al.:Motor Neuron-specific Disruption of Proteasomes, but not Autophagy, Replicates Amyotrophic Lateral Sclerosis. J. Biol. Chem.,:,2012
PubMed
31) Inoue, H. et al.:The crucial role of caspase-9 in the disease progression of a transgenic ALS mouse model. Embo J., 22:6665-6674, 2003
PubMed
32) Boillee, S. et al.:Onset and progression in inherited ALS determined by motor neurons and microglia.Science, 312:1389-1392, 2006
PubMed
33) Yamanaka, K. et al.:Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci., 11:251-253, 2008
PubMed
34) Custer, S. K. et al.:Bergmann glia expression of polyglutamine-expanded ataxin-7 produces neurodegeneration by impairing glutamate transport.at. Neurosci., 9:1302-1311, 2006
PubMed
35) Munch, C. et al.:Prion-like propagation of mutant superoxide dismutase-1 misfolding in neuronal cells.Proc. Natl. Acad. Sci. USA, 108:3548-3553, 2011
PubMed
36) Chia, R. et al.:Superoxide dismutase 1 and tgSOD1 mouse spinal cord seed fibrils, suggesting a propagative cell death mechanism in amyotrophic lateral sclerosis. PLoS One, 5:e10627, 2010
PubMed
37) Garden, G. A. & La Spada, A. R.:Intercellular (mis) communication in neurodegenerative disease. Neuron, 73:886-901, 2012
PubMed
38) Sun, W. et al.:Overexpression of HGF retards disease progression and prolongs life span in aransgenic mouse model of ALS. J. Neurosci., 22:6537-6548, 2002
PubMed
39) Ishigaki, A. et al.:Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model. J. Neuropathol.xp. Neurol., 66:1037-1044, 2007
 
40) Ralph, G. S. et al.:Silencing mutant SOD1 using RNAi protects against neurodegeneration and extends survival in an ALS model. Nat. Med., 11:429-433, 2005
 
41) Raoul, C. et al.:Lentiviral-mediated silencing of SOD1 through RNA interference retards disease onset and progression in a mouse model of ALS. Nat.Med., 11:423-428, 2005
 
42) Saito, Y. et al.:Transgenic small interfering RNA halts amyotrophic lateral sclerosis in a mouse model. J. Biol. Chem., 280:42826-42830, 2005
 
43) Murakami, G. et al.:Chemical library screening identifies a small molecule that downregulates SOD1 transcription for drugs to treat amyotrophic lateral sclerosis. J. Biomol. Screen., 16:405-414, 2011
PubMed
44) Urushitani, M. et al.:Chromogranin-mediated secretion of mutant superoxide dismutase proteins linked to amyotrophic lateral sclerosis. Nat.Neurosci., 9:108-118, 2006
PubMed
45) Urushitani, M. et al.:Therapeutic effects of immunization with mutant superoxide dismutase in mice models of amyotrophic lateral sclerosis. Proc.Natl. Acad. Sci. USA, 104:2495-2500, 2007
PubMed
46) Gros-Louis, F. et al.:Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS. J.Neurochem., 113:1188-1199, 2010
PubMed
47) Inoue, H.:Neurodegenerative disease-specific induced pluripotent stem cell research. Exp. Cell Res., 316:2560-2564, 2010
PubMed
48) Dimos, J. T. et al.:Induced pluripotent stem cells generated from patiens with ALS can be differentiated into motor neurons. Science, 321:1218-1221, 2008
 
49) Katsuno, M. et al.:Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron, 35:843-854, 2002
 
50) Katsuno, M. et al.:Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study):a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol., 9:875-884, 2010
PubMed
51) Ince, P. G. et al.:Molecular pathology and genetic advances in amyotrophic lateral sclerosis:an emerging molecular pathway and the significance of glial pathology. Acta Neuropathol., 122:657-671,2011
PubMed
52) Lee, E. B. et al.:Gains or losses:molecular mechanisms of TDP43-mediated neurodegeneration. Nat. Rev.Neurosci., 13:38-50, 2011
 
53) Joyce, P. I. et al.:SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis:recent advances in understanding disease toward the development of clinical treatments. Mamm. Genome, 22:420-448,2011
PubMed
54) Ilieva, H. et al.:Non-cell autonomous toxicity in neurodegenerative disorders:ALS and beyond. J. Cell Biol., 187:761-772, 2009
PubMed
55) Philips, T. & Robberecht, W.:Neuroinflammation inmyotrophic lateral sclerosis:role of glial activation in motor neuron disease. Lancet Neurol., 10:253-263, 2011
PubMed
56) Polymenidou, M. & Cleveland, D. W.:The seeds of neurodegeneration:prion-like spreading in ALS.Cell, 147:498-508, 2011
PubMed
P.318 掲載の参考文献
1) Hardy, J.:Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci., 20:154-159, 1997
PubMed
2) Hardy, J. & Selkoe, D. J.:The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics. Science, 297:353-356, 2002
PubMed
3) Morishima-Kawashima, M. et al.:Effect of apolipoprotein allele epsilon4 on the initial phase of amyloid beta-protein accumulation in the human brain. Am. J. Pathol., 157:2093-2099, 2000
 
4) Hutton, M. et al.:Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature, 393:702-705, 1998
 
5) Lee, V. M.-Y. & Trojanowski, J. Q.:Neurodegenerativetauopathies:human disease and transgenic mouse models. Neuron, 24:507-510, 1999
 
6) Selkoe, D. J.:Physiological production of the beta-amyloidrotein and the mechanism of Alzheimer's disease. Trends Neurosci., 16:403-409, 1993
PubMed
7) Saito, T. et al.:Potent amyloidogenicity and pathogenicity of Aβ43. Nat. Neurosci., 14:1023-1032, 2011
 
8) Vassar, R. et al.:Beta-secretase cleavage of Alzheimer's myloid precursor protein by the transmembrane aspartic protease BACE. Science, 286:735-741,1999
 
9) Dominguez, D. et al.:Phenotypic and biochemical analyses of BACE1-and BACE2-deficient mice. J.Biol. Chem., 280:30797-30806, 2005
PubMed
10) Zhou, L. et al.:The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease inivo. J. Biol. Chem., 287:25927-25940, 2012
PubMed
11) Alzheimer Research ForumのAPP変異のページ (http://www.alzforum.org/res/com/mut/app/default.sp)
 
12) Alzheimer Research Forumののプレセニリン変異のページ (http://www.alzforum.org/res/com/mut/pre/efault.asp)
 
13) Koo, E. H. & Kopan, R.:Potential role of presenilin regulated signaling pathways in sporadic neurodegeneration. Nat. Med., 10:S26-S33, 2004
PubMed
14) Jacobsen, J. S. et al.:The release of Alzheimer's disease beta amyloid peptide is reduced by phorbol treatment. J. Biol. Chem., 269:8376-8382, 1994
PubMed
15) Saido, T. C. & Iwata, N.:Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis,prevention and therapy. Neurosci. Res., 54:235-253, 200
 
16) Iwata, N. et al.:Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma:suppression leads to biochemical and pathological deposition. Nat. Med., 6:143-150,2000
PubMed
17) Iwata, N. et al.:Metabolic regulation of brain Abeta by neprilysin. Science, 292:1550-1552, 2001
PubMed
18) Iwata, N. et al.:Region-specific reduction of A beta-degradingndopeptidase, neprilysin, in mouse hippocampus upon aging. J. Neurosci. Res., 70:493-500, 2002
PubMed
19) Iwata, N. et al.:Presynaptic localization of neprilysin contributes to efficient clearance of amyloid-beta peptide in mouse brain. J. Neurosci.,24:991-998, 2004
 
20) Saito, T. et al.:Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat. Med., 11:434-439,2005
PubMed
21) Barral, S. et al.:Genotype patterns at PICALM, CR1,BIN1, CLU, and APOE genes are associated with episodic memory. Neurology, 78:1464-1471, 2012
PubMed
22) Stephan, A. H. et al.:The complement system:an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci.,35:369-389, 2012
PubMed
23) Schenk, D. et al.:Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the DAPP mouse. Nature, 400:173-177, 1999
 
24) Schenk, D.:Amyloid-beta immunotherapy for Alzheimer's disease:the end of the beginning. Nat.ev. Neurosci., 3:824-828, 2002
 
25) Hara, H. et al.:Mucosal immunotherapy in an Alzheimer mouse model by recombinant Sendai virus vector carrying Aβ1-43/IL-10 cDNA. Vaccine,29:7474-7482, 2011
 
26) Price, D. L. et al.:Alzheimer's disease:genetic studies and transgenic models. Annu. Rev. Genet.,32:461-493, 1998
PubMed
27) Duff, K.:Recent work on Alzheimer's disease transgenics. Curr. Opin. Biotechnol., 9:561-564,1998
PubMed
28) Oddo, S. et al.:Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome. Neuron, 43:321-332, 2004
PubMed
P.325 掲載の参考文献
1) Dunnett, S. B. & Bjorklund, A.:Prospects for new restorative and neuroprotective treatments in Parkinson's disease. Nature, 399:A32-A39, 1999
PubMed
2) Langston, J. W.:The etiology of Parkinson's disease with emphasis on the MPTP story. Neurology, 47:153-S160, 1996
 
3) Mizuno, Y. et al.:Mitochondrial dysfunction in Parkinson's disease. Ann. Neurol., 44:S99-S109,1998
PubMed
4) Polymeropoulos, M. H. et al.:Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276:2045-2047, 1997
PubMed
5) Spillantini, M. G. et al.:Alpha-synuclein in Lewy bodies. Nature, 388:839-840, 1997
PubMed
6) Baba, M. et al.:Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am. J. Pathol., 152:879-884, 1998
PubMed
7) Kitada, T. et al.:Mutations in the parkin gene cause utosomal recessive juvenile parkinsonism. Nature,392:605-608, 1998
 
8) Valente, E. M. et al.:Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science, 304:1158-1160, 2004
PubMed
9) Bonifati, V. et al.:Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science, 299:256-259, 2003
 
10) Kawajiri, S. et al.:Genetic mutations and functions of PINK1. Trends Pharmacol. Sci., 32:573-580,2011
PubMed
11) Guzman, J. N. et al.:Oxidant stress evoked by pacemaking in dopaminergic neurons is attenuated by DJ-1. Nature, 468:696-700, 2010
PubMed
12) Paisan-Ruiz, C. et al.:Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron, 44:595-600, 2004
PubMed
13) Zimprich, A. et al.:Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron, 44:601-607, 2004
PubMed
14) Simon-Sanchez, J. et al.:Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet., 41:1308-1312, 2009
PubMed
15) Satake, W. et al.:Genome-wide association study identifies common variants at four loci as geneticisk factors for Parkinson's disease. Nat. Genet., 41:1303-1307, 2009
PubMed
16) Lang, A. E. et al.:Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann. Neurol.,59:459-466, 2006
PubMed
17) Kiskinis, E. & Eggan, K.:Progress toward the clinical application of patient-specific pluripotent stem cells. J. Clin. Invest., 120:51-59, 2010
PubMed
P.333 掲載の参考文献
1) La Spada, A. R. et al.:Androgen receptor geneutations in X-linked spinal and bulbar musculartrophy. Nature, 352:77-79, 1991
 
2) Huntington's Disease Collaborative Researchroup:A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell, 72:971-983, 1993
 
3) Orr, H. T. et al.:Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat.Genet., 4:221-226, 1993
PubMed
4) Koide, R. et al.:Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat. Genet., 6:9-13, 1994
PubMed
5) Nagafuchi, S. et al.:Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat. Genet., 6:14-18, 1994
PubMed
6) Kawaguchi, Y. et al.:CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet., 8:221-228, 1994
 
7) Kakizuka, A.:Degenerative ataxias:genetics, pathogenesis and animal models. Curr. Opin.Neurol., 10:285-290, 1997
PubMed
8) Nakamura, K. et al.:SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum. Mol.enet., 10:1441-1448, 2001
 
9) Katsuno, M. et al.:Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron, 35:843-854, 2002
 
10) Kakizuka, A.:Protein precipitation:a common etiology in neurodegenerative disorders? Trends Genet., 14:396-402, 1998
PubMed
11) Holmes, S. E. et al.:Expansion of a novel CAG trinucleotide repeat in the 5' region of PPP2R2B is associated with SCA12. Nat. Genet., 23:391-392,1999
PubMed
12) Koob, M. D. et al.:An untranslated CTG expansion aauses a novel form of spinocerebellar ataxia (SCA8). Nat. Genet., 21:379-384, 1999
 
13) Matsuura, T. et al.:Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type10. Nat. Genet., 26:191-194, 2000
 
14) Ikeda, H. et al.:Expanded polyglutamine in the Machado-Joseph disease protein induces cell death in vitro and in vivo. Nat. Genet., 13:196-202, 1996
PubMed
15) Mangiarini, L.:Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenicice. Cell, 87:493-506, 1996
 
16) Kobayashi, T. & Kakizuka, A.:Molecular analyses of Machado-Joseph disease Cytogenet, Genome Res.,100:261-275, 2003
PubMed
17) Neumann, M. et al.:Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314:130-133, 2006
 
18) Yamamoto, A. et al.:Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell, 101:57-66, 2000
 
19) Nishitoh, H. et al.:ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev., 16:1345-1355, 2002
PubMed
20) Bence, N. F. et al.:Impairment of the ubiquitin proteasome system by protein aggregation. Science,292:1552-1555, 2001
PubMed
21) Shimohata, T. et al.:Expanded polyglutamine stretches interact with TAF II 130, interfering with REB-dependent transcription. Nat. Genet., 26:29-36, 2000
 
22) Nucifora, F. C. Jr. et al.:Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science, 291:2423-2428, 2001
PubMed
23) Cui, L. et al.:Transcriptional repression of PGC-1 alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell, 127:59-69, 2006
PubMed
24) Koike, M. et al.:Valosin-containing protein (VCP) in novel feedback machinery between abnormal protein accumulation and transcription a luppression. J. Biol. Chem., 285:21736-21749,2010
PubMed
25) Ferrante, R. J. et al.:Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J. Neurosci., 23:9418-9427, 2003
PubMed
26) Saudou, F. et al.:Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell, 95:55-66, 1998
 
27) Kawaguchi, Y. et al.:The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell, 115:727-738, 2003
PubMed
28) Senchez, I. et al.:Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature, 421:373-379, 2003
 
29) Tanaka, M. et al.:Trehalose alleviates polyglutaminemediated pathology in a mouse model of Huntington disease. Nat. Med., 10:148-154, 2004
 
30) Katsuno, M. et al.:Pharmacological induction of heat-shock proteins alleviates polyglutaminemediated motor neuron disease. Proc. Natl. Acad.ci. USA, 102:16801-16806, 2005
 
31) Ravikumar, B. et al.:Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet., 36:585-595, 2004
 
32) Tonoki, A. et al.:Genetic evidence linking age dependent attenuation of the 26S proteasome with the aging process. Mol. Cell. Biol., 29:1095-1106,2009
PubMed
33) Alavez, S. et al.:Amyloid-binding compounds maintain protein homeostasis during ageing and extend lifespan. Nature, 472:226-229, 2011
PubMed
34) Katsuno, M. et al.:Leuprorelin rescues polyglutamine dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med.,9:768-773, 2003
 
35) Waza, M. et al.:17-AAG, an Hsp90 inhibitor, ameliorates polyglutamine-mediated motor neuron degeneration.Nat. Med., 11:1088-1095, 2005
PubMed
36) Banno, H. et al.:Phase 2 trial of leuprorelin in patients with spinal and bulbar muscular atrophy.Ann. Neurol., 65:140-150, 2009
PubMed
37) Katsuno, M. et al.:Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study):a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol., 9:875-884, 2010
PubMed
38) van Dellen, A. et al.:Delaying the onset of Huntington's in mice. Nature, 404:721-722, 2000
 
39) Lazarov, O. et al.:Environmental enrichment reduces A beta levels and amyloid deposition in transgenic mice. Cell, 120:701-713, 2005
PubMed
40) Kakizuka, A.:Roles of VCP in human neurodegenerative disorders. Biochem. Soc. Trans., 36:105-108, 2008
PubMed

第8章 さまざまな実験手法

P.343 掲載の参考文献
1) Bliss, T. V. & Lomo, T.:Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant path. J. Physiol., 232:337-356, 1973
 
2) 『The organization of behavior:a neuropsychological theory』(Hebb, D. O.), Wiley, 1949
 
3) Nicolelis, M. A. & Ribeiro, S.:Multielectrode recordings:the next step. Curr. Opin. Neurobiol., 12:602-606, 2002
 
4) Oka, H. et al.:A new planar multielectrode array for extracellular recording:application to hippocampal acute slice. J. Neurosci. Methods, 93:61-67, 1999
PubMed
5) Neher, E. & Sakmann, B.:Single channel currents recorded from membrane of denervated frog muscle fibers. Nature, 260:799-802, 1976
PubMed
6) Hamill, O. P. et al.:Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch., 391:85-100, 1981
PubMed
7) 『パッチクランプ実験技術法』(岡田泰伸/編), 吉岡書店, 1996
 
8) Edward, F. A. et al.:A thin slice preparation for patch clamp recordings from neurones of the mammalian central nervous system. Pflugers Arch., 414:600-612, 1989
 
9) Kaneda, M. et al.:Mechanical and enzymatic isolation of mammalian CNS neurons. Neurosci. Res., 5:299-315, 1988
PubMed
10) Harata, N. et al.:Run-down of the GABAA response under experimental ischaemia in acutely dissociated CA1 pyramidal neurones of the rat. J. Physiol., 500:673-688, 1997
 
11) Penner, R. & Neher, E.:The patch-clamp techniques in the study of secretion. TINS, 12:159-163, 1989
 
12)『 Single channel recording 2nd edition』(Sakmann,B. & Neher, E.), Plenum Press, 1995
 
13) Kanno, T. et al.:Noradrenaline stimulates ATP release from DRG neurons by targeting β3 adrenoceptors as a factor of neuropathic pain. J. Cell. Physiol., 224:345-351, 2010
 
14)『 Methods for Neural Ensemble Recordings 2nd edition』(Nicolelis, M. A. L.), CRC Press, 2008
 
P.350 掲載の参考文献
1) 『Culturing nerve cells』(Banker, G. & Goslin, K. /d.), The MIT Press, 1990
 
2) 『Culture of Animal Cells 3rd ed.』(Freshrey, R. I.), Wiley-Liss, 1994
 
3) 『脳神経研究の進めかた』(真鍋俊也, 他/編), 無敵のバイオテクニカルシリーズ, 羊土社, 1998
 
4) 『神経生物学のための遺伝子導入発現法』(吉川和明/編. 中川八郎/シリーズ監修), シュプリンガー・フェアラーク東京, 1997
 
5) 『遺伝子導入 & 発現解析実験法』(斎藤 泉, 菅野純夫/編). ザ・プロトコールシリーズ, 羊土社, 1997
 
P.358 掲載の参考文献
1) Denk, W. et al.:Two-photon laser scanning fluorescence microscopy. Science, 248:73-76, 1990 823-839, 2006
 
2) Svoboda, K. & Yasuda, R:Principles of two-phoon excitation microscopy and its applications to neuroscience. Neuron, 50:823-839, 2006
 
3) Helmchen, F. & Denk, W.:Deep tissue two photon microscopy. Nat. Methods, 2:932-940, 2005
PubMed
4) Stosiek, C. et al.:In vivo two photon calcium imaging of neuronal networks. Proc. Natl. Acad. Sci. USA, 100:7319-7324, 2003
PubMed
5) Ohki, K. & Reid, R. C.:Specificity and randomness in the visual cortex. Curr. Opin. Neurobiol., 17:401-407, 2007
PubMed
6) Svoboda, K. et al.:In vivo dendritic calcium dynamics in neocortical pyramidal neurons. Nature, 385:161-165, 1997
PubMed
・『In Vivo Optical Imaging of Brain Function, Seconddition(Frontiers in Neuroscience)』 (Frostig, R. D. /d.), CRC Press, 2009
 
・『Imaging in Neuroscience:A Laboratory Manual』 Helmchen, F. & Konnerth, A. /ed.), CSHL Press, 2011
 
P.364 掲載の参考文献
1) Nagel, G. et al.:Channelrhodopsin-2, a directly light-gated cation-selective membrane channel.Proc. Natl. Acad. Sci. USA, 100:13940-13945,2003
PubMed
2) Boyden, E. S. et al.:Millisecond-timescale, genetically targeted optical control of neural activity. Nat.Neurosci., 8:1263-1268, 2005
PubMed
3) Zhang, F. et al.:The microbial opsin family of optogenetic tools. Cell, 147:1446-1457, 2011
PubMed
4) Yizhar, O. et al.:Optogenetics in neural systems. Neuron, 71:9-34, 2011
PubMed
5) Szobota, S. & Isacoff, E. Y.:Optical control of neuronal activity. Annu. Rev. Biophys., 39:329-348, 2010
PubMed
6) Kato, H. E. et al.:Crystal structure of the channelrhodopsin light-gated cation channel. Nature, 482:369-374,2012
PubMed
7) Zhang, F. et al.:Multimodal fast optical interrogation of neural circuitry. Nature, 446:633-639, 2007
PubMed
8) Chow, B. Y. et al.:High-performance genetically targetable optical neural silencing by light-driven proton pumps. Nature, 463:98-102, 2010
PubMed
9) Schroder Lang, S. et al.:Fast manipulation of cellular cAMP level by light in vivo. Nat. Methods, 4:39-42,2007
PubMed
10) Wu, Y. I. et al.:A genetically encoded photoactivatable Rac controls the motility of living cells. Nature,461:104-108, 2009
PubMed
P.375 掲載の参考文献
1) Sokoloff, L.:Local cerebral circulation at rest and during altered cerebral activity induced by anesthesia or visual stimulation. 『 The Regional Chemistry, Physiology and Pharmacology of the Nervous System』 (Kety, S. S. & Elkes, J. /ed.),p107-117, Pergamon Press, 1961
 
2) Fox, P. T. et al.:A noninvasive approach to quantitative functional brain mapping with H215O and positron emission tomography. J. Cereb. Blood Flow Metab.,4:329-333, 1984
 
3) Belliveau, J. W. et al.:Functional cerebral imaging by susceptibility contrast NMR. Magn. Reson. Med.,14:538-546, 1990
PubMed
4) Ogawa, S. et al.:Oxygenation sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn. Reson. Med., 14:68-78,1990
 
5) Sokoloff, L.:A historical review of developments in the field of cerebral blood flow and metabolism. 『 Keio University International Symposium for Life Sciences and Medicine, Volume 6, Ischemic Blood Flow in the Brain』(Fukuuchi, Y. et al. /ed.), pp3-10, Springer erlag, 2001
 
6) Nakada, T.:Myths and truths in functional MRI:A basic guide for practitioners. Magn. Reson. Med.Sci., 1:89-107, 2002
PubMed
7) Nakada, T. et al.:Independent component-crossorrelation-sequential epoch(ICS)analysis of high field fMRI time series:direct visualization of dual representation of the primary motor cortex inuman. Neurosci. Res., 37:237-244, 2000
 
8) Suzuki, K. et al.:Fast and precise independent component analysis for high field fMRI time series tailored using prior information on spatiotemporal structure. Human Brain Map, 15:54-66, 2002
PubMed
9) Nakada, T. et al.:Planum temporale where spoken and written language meet. European Neurol., 46:121-125, 2001
 
10) Fujii, Y. & Nakada, T.:Cortical reorganization in subcortical hemiparesis:neural mechanisms of functional recovery and prognostic implication. J.Neurosurg., 98:64-73, 2003
PubMed
11) Nakada, T. et al.:Coerced training of the non-dominant hand results in cortical reorganization:high-field fMRI study. J. Neurosurg., 101:310-313,2004
 
P.382 掲載の参考文献
1) Gordon, J. W. et al.:Genetic transformation of mouse embryos by microinjection of purified DNA.Proc. Natl. Acad. Sci. USA, 77:7380-7384, 1980
PubMed
2) 『ジーンターゲティング-ES細胞を用いた変異マウスの作製(実験医学別冊バイオマニュアルシリーズ8)』(相沢慎一/著), 羊土社, 1995
 
3) 『Manipulating the mouse embryo-a laboratory manual, 3rd Ed』 (Nagy, A. et al.), Cold Springarbor Laboratory Press, 2003
 
4) 『モデル動物の作製と維持』(森脇和郎, 他/編), エル・アイ・シー, 2004
 
5) 『マウスラボマニュアル 第2版-ポストゲノム時代の実験法』(東京都臨床医学総合研究所実験動物研究部門/編), シュプリンガー・フェアラーク東京, 2003
 
6) Mishina, M. & Sakimura, K.:Conditional gene targeting on the pure C57BL/6 genetic background.Neurosci. Res., 58:105-112, 2007
PubMed
7) 『Molecular cloning-a laboratory manual』(Sambrook, J. & Russell, D. W.),Cold Spring Harbor Laboratoryress, 200179:340-349,2007
 
8) 崎村建司, 他: 新世代のジーンターゲティング, 生化学, 79: 340-349, 2007
 
9) Silva, A. J. et al.:Impaired spatial learning in α-calcium-calmodulin kinase II mutant mice. Science, 257:206-211, 1992
 
10) Sakimura, K. et al.:Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor ε 1 subunit. Nature, 373:151-155, 1995
 
11) Kitayama, K. et al.:Purkinje cell specific and inducible gene recombination system generated from C57BL/6 mouse ES cells. Biochem. Biophys. Res.Commun., 281:1134-1140, 2001
PubMed
12) Mayford, M. et al.:Control of memory formation through regulated expression of a CaMKII transgene.Science, 274:1678-1683, 1996
PubMed
P.388 掲載の参考文献
1) Wasinger, V. C. et al.:Progress with gene product mapping of the Mollicutes:Mycoplasma genitalium.Electrophoresis, 16:1090-1094, 1995
PubMed
2) Schmutz, J. et al.:Quality assessment of the human genome sequence. Nature, 429:365-368, 2004
PubMed
3) Schena, M.:Genome analysis with gene expression microarrays. Bioessays, 18:427-431, 1996
PubMed
4) Gunderson, K. L. et al.:Mutation detection by ligation to complete n-mer DNA arrays. Genomees., 8:1142-1153, 1998
PubMed
5) Wolters, D. A. et al.:An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem., 73:5683-5690, 2001
PubMed
6) Merchant, M. & Weinberger, S. R.:Recent advancements in surface-enhanced laser desorption/ionization time of flight mass spectrometry. Electrophoresis, 21:1164-1177, 2000
PubMed
7) O'Farrell, P. H.:High resolution two dimensional electrophoresis of proteins. J. Biol. Chem., 250:4007-4021, 1975
PubMed
8) Unlu, M. et al.:Difference gel electrophoresis:a single gel method for detecting changes in protein extracts. Electrophoresis, 18:2071-2077, 1997
PubMed
9) Garrels, J. I.:Two dimensional gel electrophoresis and computer analysis of proteins synthesized by clonal cell lines. J. Biol. Chem., 254:7961-7977,1979
PubMed
10) Steinberg, T. H.:Ultrasensitive fluorescence protein detection in isoelectric focusing gels using a ruthenium metal chelate stain. Electrophoresis, 21:486-496,2000
PubMed
11) DeSouza, L. et al.:Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J.Proteome Res., 4:377-386, 2005
PubMed
12) Kuyama, H. et al.:An approach to quantitative proteome analysis by labeling tryptophan residues.Rapid Commun. Mass Spectrom., 17:1642-1650,2003
PubMed
13) Boja, E. S. & Rodriguez, H.:Mass spectrometry-based targeted quantitative proteomics:achieving sensitive and reproducible detection of proteins.Proteomics, 12:1093-1110, 2012
PubMed
14) Rezeli, M. et al.:MRM assay for quantitation of complement components in human blood plasma feasibility study on multiple sclerosis. J. Proteomics,75:211-220, 2011
PubMed

書評

最近チェックした商品履歴

Loading...